var title_f19_59_20400="Arthritis mutilans in psoriasis";
var content_f19_59_20400=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F51683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F51683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Arthritis mutilans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arthritis mutilans in psoriatic arthritis with marked deformity and destruction of digits.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter H Schur, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20400=[""].join("\n");
var outline_f19_59_20400=null;
var title_f19_59_20401="Action potential currents";
var content_f19_59_20401=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F70771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F70771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 628px\">",
"   <div class=\"ttl\">",
"    Action potential currents",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 608px; height: 435px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cardiac ion currents responsible for generation of the action potential. The commonly used symbols and name are given for each of the major currents along with the name for the &beta;-subunit gene and, where different, the &alpha;-subunit protein. Most channels and exchangers have &beta;-subunits and associated proteins not shown here. In some cases alternative earlier gene names are given after the formal gene name. Diagrams of the currents are shown synchronized with the action potential but amplitudes are not drawn to scale.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan C Makielski, MD, FACC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20401=[""].join("\n");
var outline_f19_59_20401=null;
var title_f19_59_20402="Pulmonary hypertension short axis echo";
var content_f19_59_20402=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/67911/shaxpuhy_conv.mp4?title=Pulmonary+hypertension+short+axis+echo\" style=\"width:328px;height:248px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary hypertension short axis echocardiographic view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 243px; height: 417px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The short axis view from a 2-D echocardiogram shows significant right ventricular&nbsp;pressure and volume overload&nbsp;as a result of pulmonary hypertension.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Provided by Thomas Binder, MD, et al. Interactive Echocardiography. A Clinical Atlas. Futura, 1997.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20402=[""].join("\n");
var outline_f19_59_20402=null;
var title_f19_59_20403="Forceps of aftercoming head 1";
var content_f19_59_20403=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Forceps applied to after-coming head",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The head has entered the pelvis and forceps have been applied.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pritchard, JA, MacDonald, PC. Williams Obstetrics, 16th Edition, Appleton-Century-Crofts, New York 1980. Copyright &copy;1980 McGraw Hill. p.1071.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20403=[""].join("\n");
var outline_f19_59_20403=null;
var title_f19_59_20404="Lichen sclerosus vulvar";
var content_f19_59_20404=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lichen sclerosus of the vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rodriguez MI, Leclair CM. Benign vulvar dermatoses. Obstet Gynecol Surv 2012; 67:55. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20404=[""].join("\n");
var outline_f19_59_20404=null;
var title_f19_59_20405="Investigational approaches for the treatment of advanced prostate cancer";
var content_f19_59_20405=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Investigational approaches for the treatment of advanced prostate cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Janet R Walczak, MSN, RN, CRNP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Roberto Pili, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Michael A Carducci, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Emmanuel S Antonarakis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Nicholas Vogelzang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20405/contributors\">",
"     W Robert Lee, MD, MS, MEd",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20405/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/59/20405/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen deprivation therapy (ADT) is highly effective therapy for men with advanced or metastatic prostate cancer, providing at least temporary disease control in over 80 percent of cases. However, the vast majority eventually develop progressive disease.",
"   </p>",
"   <p>",
"    Once disease progresses, men are considered to have castrate resistant disease. A number of new therapies have been shown to prolong survival in this setting (",
"    <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"     table 1",
"    </a>",
"    ), but there remains a need for additional approaches that can control disease and prolong survival.",
"   </p>",
"   <p>",
"    An increasing understanding of the biology of prostate cancer is leading to the development of new therapies that can target specific abnormalities in prostate cancer. Promising, experimental approaches in advanced stages of development are discussed in this topic. The overall approach to men with advanced disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=see_link\">",
"     \"Overview of the treatment of disseminated prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TARGETED THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prostate cancers are frequently characterized by abnormalities in a variety of growth factor signaling pathways that control the cell cycle and apoptosis. As these pathways are being understood, new therapeutic targets are leading to the development of new agents with activity against advanced disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/9/30874?source=see_link\">",
"     \"Molecular biology of prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518894354\">",
"    <span class=\"h2\">",
"     Dasatinib",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/39/22136?source=see_link\">",
"     Dasatinib",
"    </a>",
"    is a src",
"    <span class=\"nowrap\">",
"     family/abl",
"    </span>",
"    inhibitor with preclinical activity in prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Results from phase II studies suggested that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/39/22136?source=see_link\">",
"     dasatinib",
"    </a>",
"    had useful clinical activity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. On this basis, a phase III trial (NCT00744497) was conducted, in which 1522 men with metastatic castration resistant prostate cancer were randomly assigned to either dasatinib with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    or docetaxel plus prednisone alone. Preliminary results presented at the 2013 ASCO Genitourinary Symposium found no improvement in overall survival, the primary endpoint of the trial, with a median follow-up of 19 months (median 21.5 versus 21.2 months, hazard ratio 0.99) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518894361\">",
"    <span class=\"h2\">",
"     Cabozantinib",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/22/7526?source=see_link\">",
"     Cabozantinib",
"    </a>",
"    (XL184) is an inhibitor of MET, VEGFR2, and RET. Cabozantinib has shown preliminary evidence of activity against bone metastases in patients with castration-resistant prostate cancer.",
"   </p>",
"   <p>",
"    In a phase II randomized discontinuation trial, 171 patients with measurable, progressive metastatic castrate resistant prostate cancer received 12 weeks of treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/22/7526?source=see_link\">",
"     cabozantinib",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/5\">",
"     5",
"    </a>",
"    ]. After the initial treatment, patients with a partial or complete response were allowed to continue treatment in an open label extension. Those with stable disease were randomized to cabozantinib or placebo, while those who received placebo were given cabozantinib. Patients with progressive disease after the initial 12 weeks of treatment and those who progressed on cabozantinib following randomization came off protocol.",
"   </p>",
"   <p>",
"    Although only 5 percent of patients met RECIST criteria for a partial response at 12 weeks, 72 percent had regression of soft tissue lesions and 68 percent of evaluable patients had improvement on bone scan. Among the 31 patients who were randomized after the initial 12 weeks of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/22/7526?source=see_link\">",
"     cabozantinib",
"    </a>",
"    treatment, progression-free survival following randomization was significantly longer with cabozantinib compared with placebo (24 versus 6 weeks, hazard ratio 0.12). Bone turnover markers (total alkaline phosphatase, C-terminal telopeptide) decreased 57 percent in evaluable patients. Subjective improvement in bone pain was seen in 67 percent of cases, and 56 percent decreased or stopped narcotic usage. The toxicities observed in more than 40 percent of cases included fatigue, decreased appetite, diarrhea, and nausea, in 63, 54, 51, and 49 percent of cases, respectively.",
"   </p>",
"   <p>",
"    Two phase III trials have been initiated in men who have progressed on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    and either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    as treatment for bone metastases from castrate resistant prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the COMET-1 trial, men are being randomly assigned to either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/22/7526?source=see_link\">",
"       cabozantinib",
"      </a>",
"      or to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (",
"      <a class=\"external\" href=\"file://www.clinicaltrials.gov/ct2/show/NCT01605227?term=NCT01605227&amp;rank=1\">",
"       NCT01605227",
"      </a>",
"      ). The primary endpoint of this trial is overall survival.",
"     </li>",
"     <li>",
"      In the COMET-2 trial, patients are being randomly assigned to either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/22/7526?source=see_link\">",
"       cabozantinib",
"      </a>",
"      or to a combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/31/37368?source=see_link\">",
"       mitoxantrone",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (",
"      <a class=\"external\" href=\"file://www.clinicaltrials.gov/ct2/show/NCT01522443?term=NCT01522443&amp;rank=1\">",
"       NCT01522443",
"      </a>",
"      ). The primary endpoint of this trial is confirmed durable pain response.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/22/7526?source=see_link\">",
"     Cabozantinib",
"    </a>",
"    is now approved for use in medullary thyroid cancer (at a dose of 140",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"    The dose being test in the two phase III prostate cancer trials is 60",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Custirsen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiapoptotic proteins such as clusterin and survivin are expressed at high levels in prostate cancer cells that survive androgen deprivation therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/9/30874?source=see_link&amp;anchor=H29#H29\">",
"     \"Molecular biology of prostate cancer\", section on 'Acquired androgen resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Custirsen, an antisense oligonucleotide directed against clusterin, an antiapoptotic protein that is expressed at high levels in prostate cancer cells that have progressed after androgen deprivation therapy. The antisense approach to cancer therapy involves targeting specific RNA sequences by constructing complementary oligonucleotides that bind to the native mRNA sequences and reduce their translation and subsequent protein expression. These oligonucleotides can theoretically be targeted against numerous genes involved in cellular proliferation, apoptosis, metastasis, and angiogenesis.",
"   </p>",
"   <p>",
"    Custirsen downregulated clusterin expression in primary prostate cancers in a phase I study [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/7\">",
"     7",
"    </a>",
"    ]. However, in a randomized phase II trial in which custirsen was combined with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , there was no statistically significant improvement in rates of PSA decline, objective response rate or progression-free survival, although there was a trend toward increased overall survival [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Custirsen is being further evaluated in two randomized phase III trials. In one, patients receiving second line chemotherapy (either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    retreatment or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/47/31478?source=see_link\">",
"     cabazitaxel",
"    </a>",
"    ) are being randomly assigned to custirsen or placebo for the control of pain (NCT01083615). In the other, custirsen or placebo is being combined with the docetaxel plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    regimen to assess the effect on overall survival in men with castrate resistant prostate cancer (NCT01188187) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8637120\">",
"    <span class=\"h2\">",
"     Tasquinimod",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tasquinimod is a small molecule that showed significant activity in various preclinical models. The mechanism of action has not been fully elucidated, but it has shown antiangiogenic effects both in vitro and in vivo. In phase I tasquinimod had a favorable safety profile and there was some evidence of antitumor activity.",
"   </p>",
"   <p>",
"    A multicenter randomized phase II trial was conducted in which 206 chemotherapy-na&iuml;ve men with castrate-resistant prostate cancer were randomly assigned to tasquinimod or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/10\">",
"     10",
"    </a>",
"    ]. There was a statistically significant improvement in the percentage of men free of disease progression at six months, the primary endpoint of the study (69 versus 34 percent, relative risk 0.47).",
"   </p>",
"   <p>",
"    A phase III trial is being conducted, in which asymptomatic or mildly symptomatic men with castrate-resistant, metastatic prostate cancer are randomly assigned to tasquinimod or placebo (NCT01234311) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H955750738\">",
"    <span class=\"h2\">",
"     Endothelin receptor antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two orally-active endothelin receptor antagonists, atrasentan and zibotentan, have been extensively studied to target the supporting environment for metastatic growth. Based upon phase II results, multiple phase III trials were conducted with both atrasentan [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/11-13\">",
"     11-13",
"    </a>",
"    ] and zibotentan [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20405/abstract/14\">",
"     14",
"    </a>",
"    ]. None of these trials showed significant benefit compared with placebo, and these agents are no longer being actively developed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H347808583\">",
"    <span class=\"h1\">",
"     ANDROGEN PATHWAY INHIBITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An improved understanding of the role of androgens in stimulating the growth of prostate cancer led to the development of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    , both of which have significantly improved overall survival compared with placebo in phase III trials in patients with castrate resistant prostate cancer. These agents, along with other novel approaches to inhibiting androgenic stimulation of prostate cancer, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=see_link\">",
"     \"Castrate resistant prostate cancer: Treatments targeting the androgen pathway\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H347808591\">",
"    <span class=\"h1\">",
"     IMMUNOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=see_link\">",
"     Sipuleucel-T",
"    </a>",
"    is a dendritic cell vaccine that is prepared from peripheral blood mononuclear cells obtained by leukapheresis. In randomized trials, sipuleucel-T prolonged overall survival compared with placebo in men with minimally symptomatic, metastatic prostate cancer. Sipuleucel-T and other novel immunotherapy approaches to the treatment of prostate cancer are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1254?source=see_link\">",
"     \"Immunotherapy for castration resistant prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H347808599\">",
"    <span class=\"h1\">",
"     CHEMOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Taxanes are the only cytotoxic chemotherapy agents that significantly prolonged overall survival in clinical trials in men with castrate-resistant prostate cancer.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     Docetaxel",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/47/31478?source=see_link\">",
"     cabazitaxel",
"    </a>",
"    are discussed separately, along with older chemotherapy approaches. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=see_link\">",
"     \"Chemotherapy in castrate-resistant prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H347808669\">",
"    <span class=\"h1\">",
"     RADIOPHARMACEUTICALS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radium-223 is taken up by bone and delivers alpha particles to osteoblastic metastatic disease. This approach has increased overall survival, minimized complications, and decreased symptoms in men with symptomatic advanced prostate cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link\">",
"     \"Management of bone metastases in advanced prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H261306118#H261306118\">",
"     \"Management of bone metastases in advanced prostate cancer\", section on 'Radium-223'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of patients who either present with metastatic disease or who relapse after their initial treatment for localized disease uses androgen deprivation therapy as initial therapy. Secondary hormonal therapies and chemotherapy often provide an additional period of disease control. However, most men with metastatic prostate cancer eventually develop castrate-resistant disease that cannot be controlled by currently approved modalities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=see_link\">",
"     \"Overview of the treatment of disseminated prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Key compounds with significant evidence of activity that currently are in phase III development include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/39/22136?source=see_link\">",
"       Dasatinib",
"      </a>",
"      , a src",
"      <span class=\"nowrap\">",
"       family/abl",
"      </span>",
"      inhibitor (See",
"      <a class=\"local\" href=\"#H518894354\">",
"       'Dasatinib'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/22/7526?source=see_link\">",
"       Cabozantinib",
"      </a>",
"      , an inhibitor of MET, VEGFR2, and RET (See",
"      <a class=\"local\" href=\"#H518894361\">",
"       'Cabozantinib'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Custirsen, an antisense oligonucleotide directed against clusterin, an antiapoptotic protein (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Custirsen'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tasquinimod, a small molecule which may have antiangiogenic activity (See",
"      <a class=\"local\" href=\"#H8637120\">",
"       'Tasquinimod'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whenever feasible, patients should be enrolled in formal clinical trials.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/1\">",
"      Nam S, Kim D, Cheng JQ, et al. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Res 2005; 65:9185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/2\">",
"      Yu EY, Wilding G, Posadas E, et al. Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer. Clin Cancer Res 2009; 15:7421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/3\">",
"      Araujo JC, Mathew P, Armstrong AJ, et al. Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study. Cancer 2012; 118:63.",
"     </a>",
"    </li>",
"    <li>",
"     Araujo JC, et al. Overall survival (OS) and safety of dasatinib/docetaxel versus docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC): Results from the randomized phase III READY trial. J Clin Oncol 2013; 31: (suppl 6; abstr #LBA8).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/5\">",
"      Smith DC, Smith MR, Sweeney C, et al. Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial. J Clin Oncol 2013; 31:412.",
"     </a>",
"    </li>",
"    <li>",
"     file://clinicaltrials.gov/ (Accessed on June 11, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/7\">",
"      Chi KN, Eisenhauer E, Fazli L, et al. A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer. J Natl Cancer Inst 2005; 97:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/8\">",
"      Chi KN, Hotte SJ, Yu EY, et al. Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer. J Clin Oncol 2010; 28:4247.",
"     </a>",
"    </li>",
"    <li>",
"     NIH clinical trials database: file://clinicaltrials.gov/.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/10\">",
"      Pili R, H&auml;ggman M, Stadler WM, et al. Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer. J Clin Oncol 2011; 29:4022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/11\">",
"      Carducci MA, Saad F, Abrahamsson PA, et al. A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer. Cancer 2007; 110:1959.",
"     </a>",
"    </li>",
"    <li>",
"     Quinn D, et al. SWOG S0421: Phase III study of docetaxel (D) and atrasentan (A) versus docetaxel and placebo (P) for men with advanced castrate resistant prostate cancer (CRPC)(suppl: abstract #4511). J Clin Oncol 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/13\">",
"      Nelson JB, Love W, Chin JL, et al. Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer. Cancer 2008; 113:2478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20405/abstract/14\">",
"      Nelson JB, Fizazi K, Miller K, et al. Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone. Cancer 2012; 118:5709.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6953 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-41.222.196.37-062E1C4994-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20405=[""].join("\n");
var outline_f19_59_20405=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H41\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TARGETED THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H518894354\">",
"      Dasatinib",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H518894361\">",
"      Cabozantinib",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Custirsen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8637120\">",
"      Tasquinimod",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H955750738\">",
"      Endothelin receptor antagonists",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H347808583\">",
"      ANDROGEN PATHWAY INHIBITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H347808591\">",
"      IMMUNOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H347808599\">",
"      CHEMOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H347808669\">",
"      RADIOPHARMACEUTICALS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/6953\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/6953|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/56/18317\" title=\"table 1\">",
"      Therapies for castrate resistant prostate cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=related_link\">",
"      Castrate resistant prostate cancer: Treatments targeting the androgen pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=related_link\">",
"      Chemotherapy in castrate-resistant prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1254?source=related_link\">",
"      Immunotherapy for castration resistant prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=related_link\">",
"      Management of bone metastases in advanced prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/9/30874?source=related_link\">",
"      Molecular biology of prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=related_link\">",
"      Overview of the treatment of disseminated prostate cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_59_20406="Imiquimod: Drug information";
var content_f19_59_20406=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Imiquimod: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?25/19/25908?source=see_link\">",
"    see \"Imiquimod: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F182270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aldara&reg;;",
"     </li>",
"     <li>",
"      Zyclara&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F182271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aldara&reg;;",
"     </li>",
"     <li>",
"      Vyloma&trade;;",
"     </li>",
"     <li>",
"      Zyclara&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F182299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Skin and Mucous Membrane Agent;",
"     </li>",
"     <li>",
"      Topical Skin Product",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F182273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     A rest period of several days may be taken if required by the patient's discomfort or severity of the local skin reaction. Treatment may resume once the reaction subsides. Imiquimod treatment should not be prolonged beyond recommended period due to missed doses or rest periods.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Perianal warts/condyloma acuminata:",
"     </b>",
"     Topical (Aldara&reg;): Apply a thin layer 3 times/week on alternative days prior to bedtime and leave on skin for 6-10 hours. Remove by washing with mild soap and water. Continue imiquimod treatment until there is total clearance of the genital/perianal warts (maximum duration of therapy: 16 weeks)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Actinic keratosis:",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aldara&reg;: Apply twice weekly for 16 weeks to a treatment area on face or scalp (but not both concurrently); no more than 1 packet should be applied at each application and no more than 36 packets applied per 16 weeks; apply prior to bedtime and leave on skin for 8 hours. Remove with mild soap and water.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zyclara&reg; 3.75%: Treatment consists of 2 cycles (14 days each) separated by 1 rest period (14 days) with no treatment. Apply up to 2 packets once daily at bedtime to affected area on either face or balding scalp (but not both concurrently); apply no more than 2 packets at each application and no more than 56 packets per 2 cycles of treatment. Leave on skin for 8 hours. Remove with mild soap and water.",
"     <b>",
"      Note:",
"     </b>",
"     Canadian labeling recommends avoiding application to areas larger than the face or balding scalp (~200 cm",
"     <sup>",
"      2",
"     </sup>",
"     ).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Common warts (unlabeled use):",
"     </b>",
"     Topical (Aldara&reg;): Apply once daily prior to bedtime for 5 days/week for up to 16 weeks (Hengge, 2000) or apply twice daily for up to 24 weeks (Grussendorf-Conen, 2002)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Superficial basal cell carcinoma:",
"     </b>",
"     Topical (Aldara&reg;): Apply once daily prior to bedtime, 5 days/week for 6 weeks. No more than 36 packets should be used during the 6-week treatment period. Treatment area should include a 1 cm margin of skin around the tumor. Leave on skin for 8 hours. Remove with mild soap and water.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F182288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Perianal warts/condyloma acuminata: Topical (Aldara&reg;): Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     A rest period of several days may be taken if required by the patient's discomfort or severity of the local skin reaction. Treatment may resume once the reaction subsides. Imiquimod treatment should not be prolonged beyond recommended period due to missed doses or rest periods.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F182274\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F182256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical: 5% (24s) [0.25 g/packet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aldara&reg;: 5% (12s, 24s [DSC]) [contains benzyl alcohol; 0.25 g/packet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zyclara&reg;: 3.75% (7.5 g) [contains benzyl alcohol; 0.235 g/actuation; delivers ~28 actuations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zyclara&reg;: 3.75% (28s) [contains benzyl alcohol; 0.25 g/packet]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F182241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F182258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Topical: Wash hands prior to and following application. Do not occlude the application site. Partially used packets should be discarded and not reused.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Actinic keratosis:",
"     </i>",
"     Apply Aldara&reg; over a single contiguous area (approximately 25 cm",
"     <sup>",
"      2",
"     </sup>",
"     ) on the face or scalp or Zyclara&reg; 3.75% over an area &lt;200 cm",
"     <sup>",
"      2",
"     </sup>",
"     on the face or scalp; the treatment area should be washed and thoroughly dried prior to application.  Both areas should not be treated concurrently. Apply a thin layer to the affected area and rub in until the cream is no longer visible. Avoid contact with the eyes, lips, and nostrils.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      External genital warts:",
"     </i>",
"     Aldara&reg;: Instruct patients to apply to external or perianal warts; not for vaginal use. Apply a thin layer to the wart area and rub in until the cream is no longer visible. Single-use packets contain sufficient cream to cover a wart area of up to 20 cm",
"     <sup>",
"      2",
"     </sup>",
"     ; avoid use of excessive amounts of cream.  Nonocclusive dressings (such as cotton gauze or cotton underwear) may be used in the management of skin reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Superficial basal cell carcinoma:",
"     </i>",
"     Aldara&reg;: Treatment area should have a maximum diameter no more than 2 cm on the trunk, neck, or extremities (excluding the hands, feet, and anogenital skin). Treatment area should include a 1 cm margin around the tumor. Wash and thoroughly dry treatment area prior to application; apply a thin layer to the affected area (and margin) and rub in until the cream is no longer visible. Avoid contact with the eyes, lips, and nostrils.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F182257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of external genital and perianal warts/condyloma acuminata; nonhyperkeratotic actinic keratosis on face or scalp; superficial basal cell carcinoma (sBCC) with a maximum tumor diameter of 2 cm located on the trunk, neck, or extremities (excluding hands or feet)",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F182296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of common warts",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F182306\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Aldara&reg; may be confused with Alora&reg;, Lialda&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F182297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Frequency may depend on indication/formulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Application site reactions are common. Frequency of reactions vary, and are related to the degree of inflammation associated with the treated disease, number of weekly applications, and individual sensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Burning, edema, erosion/ulceration, erythema, excoriation, flaking, induration, itching, scabbing/crusting, scaling/dryness, vesicles, weeping/exudate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Upper respiratory infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Fungal infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Chest pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Anxiety, dizziness, fatigue, fever, headache, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Alopecia, eczema, seborrhoeic keratosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Blood glucose increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, diarrhea, dyspepsia, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Bleeding, hypopigmentation, infection, irritation, pain, papule, paresthesia, pruritus, rash, scar, sensitivity, soreness, stinging, tenderness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, myalgia, rigors",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Coughing, pharyngitis, rhinitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Herpes simplex, influenza-like syndrome, lymphadenopathy, squamous cell carcinoma, tinea cruris",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports (limited to important and/or life-threatening): Abdominal pain, agitation, anemia, angioedema, arrhythmias (atrial fibrillation, palpitations, tachycardia), arthralgia, capillary leak syndrome, cardiac failure, cardiomyopathy, cerebrovascular accident, cheilitis, chills, depression, dyspnea, erythema multiforme, exfoliative dermatitis, dysuria, Henoch-Sch&ouml;nlein purpura syndrome, herpes zoster, hyperpigmentation, hypertrophic scar, idiopathic thrombocytopenia purpura, insomnia, ischemia, lethargy, leukopenia, liver function abnormal, lymphoma, MI, multiple sclerosis aggravated, pancytopenia, paresis, proteinuria, psoriasis (onset or exacerbated), pulmonary edema, seizure, spondyloarthropathy (onset or exacerbated), syncope, thrombocytopenia, thyroiditis, tingling, ulcerative colitis (onset or exacerbated), urinary retention, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10184536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed within the approved manufacturer&rsquo;s labeling.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling (not in U.S. labeling): Hypersensitivity to imiquimod or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F182245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Local inflammatory reactions: Intense local inflammatory reactions may occur after a few applications and may be accompanied by systemic symptoms (fever, malaise, myalgia); reactions may extend beyond the application site. Interruption of therapy may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity: May increase sunburn susceptibility; patients should protect themselves from the sun and artificial forms of sunlight.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Actinic keratosis: Appropriate use: Treatment should be limited to areas &le;25 cm",
"     <sup>",
"      2",
"     </sup>",
"     (Aldara&reg;) or &lt;200 cm",
"     <sup>",
"      2",
"     </sup>",
"     (Zyclara&reg; 3.75%).  Safety and efficacy of repeated use of Aldara&reg; or Zyclara&reg; 3.75% in a previously treated area have not been established. Prescribed course of therapy should be completed even if all lesions appear to be gone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Autoimmune disorders: Use caution in patients with pre-existing autoimmune disorders (onset or exacerbation of disease has been reported rarely with imiquimod).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Basal cell carcinoma: Appropriate use: Should be limited to superficial carcinomas with a maximum diameter of 2 cm. Safety and efficacy in treatment of sBCC lesions of the face, head, and anogenital area, or other subtypes of basal cell carcinoma (including nodular and morpheaform), have not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Basal cell nevus syndrome: Safety and efficacy have not been established for basal cell nevus syndrome.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Genital warts: Appropriate use: Zyclara&reg; 3.75%: Safety and efficacy in the treatment of external genital warts have not been established. Imiquimod has not been evaluated for the treatment of urethral, intravaginal, cervical, rectal, or intra-anal human papilloma viral disease and is not recommended for these conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin inflammatory conditions: Has the potential to exacerbate inflammatory conditions of the skin (including chronic graft-versus-host disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Xeroderma pigmentosum: Safety and efficacy have not been established for xeroderma pigmentosum.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunocompromised patients: Safety and efficacy have not been established in immunosuppressed patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Zyclara&reg; 3.75%: Safety and efficacy in children &lt;18 years of age have not been established. Aldara&reg;: Safety and efficacy have not been established in children &lt;12 years of age; following 2 randomized, double-blind, placebo-controlled trials, efficacy was not established for molluscum contagiosum in children 2-12 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Administration: Not intended for oral, nasal, intravaginal, or ophthalmic use. Administration is not recommended until tissue is healed from any previous drug or surgical treatment. Treatment should not be prolonged beyond recommended period due to missed doses or rest periods.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F182294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F182250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F182252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F1630402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were noted in some animal studies following oral administration. Safety and efficacy have not been established in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F182276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F182263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Aldara External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (12): $341.06",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Imiquimod External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (24): $796.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Zyclara External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3.75% (28): $888.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Zyclara Pump External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5% (7.5 g): $888.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3.75% (7.5 g): $888.59",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F182254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduction in lesion size is indicative of a therapeutic response; patients should be monitored for signs and symptoms of hypersensitivity to imiquimod",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F182264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aldara (AR, AT, AU, BE, BG, BR, CH, CL, CN, CR, CZ, DE, DK, EE, ES, FI, FR, GB, GR, GT, HK, HN, IE, IL, IT, KP, MT, MX, MY, NL, NO, NZ, PA, PH, PL, PT, RU, SE, SG, SK, SV, TH, TR, TW);",
"     </li>",
"     <li>",
"      Arsilon (UY);",
"     </li>",
"     <li>",
"      Imimore (PE);",
"     </li>",
"     <li>",
"      Inmuderm (CO);",
"     </li>",
"     <li>",
"      Miquimod (EC);",
"     </li>",
"     <li>",
"      You Care (TW);",
"     </li>",
"     <li>",
"      Youbiqing (CL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F182244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Precise mechanism of action is unknown; Toll-like receptor 7 agonist that induces cytokines, including interferon-alpha and others",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F182260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Minimal; systemic absorption more dependent upon surface area of application as opposed to dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (&le;2% of applied dose as imiquimod and metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Geisse JK, Rich P, Pandya A, et al, &ldquo;Imiquimod 5% Cream for the Treatment of Superficial Basal Cell Carcinoma: A Double-Blind, Randomized, Vehicle-Controlled Study,&rdquo;",
"      <i>",
"       J Am Acad Dermatol",
"      </i>",
"      , 2002, 47(3):390-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/12196749/pubmed\" id=\"12196749\" target=\"_blank\">",
"        12196749",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goldgeier M, Fox CA, Zavislan JM, et al, &ldquo;Noninvasive Imaging, Treatment, and Microscopic Confirmation of Clearance of Basal Cell Carcinoma,&rdquo;",
"      <i>",
"       Dermatol Surg",
"      </i>",
"      , 2003, 29(3):205-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/12614409/pubmed\" id=\"12614409\" target=\"_blank\">",
"        12614409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grussendorf-Conen EI, Jacobs S, Rubben A, et al, &ldquo;Topical 5% Imiquimod Long-Term Treatment of Cutaneous Warts Resistant to Standard Therapy Modalities,&rdquo;",
"      <i>",
"       Dermatology",
"      </i>",
"      , 2002, 205(2):139-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/12218229/pubmed\" id=\"12218229\" target=\"_blank\">",
"        12218229",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hengge UR, Esser S, Schultewolter T, et al, &ldquo;Self-Administered Topical 5% Imiquimod for the Treatment of Common Warts and Molluscum Contagiosum,&rdquo;",
"      <i>",
"       Br J Dermatol",
"      </i>",
"      , 2000, 143(5):1026-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/11069514/pubmed\" id=\"11069514\" target=\"_blank\">",
"        11069514",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Housman TS and Jorizzo JL, &ldquo;Anecdotal Reports of 3 Cases Illustrating a Spectrum of Resistant Common Warts Treated With Cryotherapy Followed by Topical Imiquimod and Salicylic Acid,&rdquo;",
"      <i>",
"       J Am Acad Dermatol",
"      </i>",
"      , 2002, 47(4 Suppl):217-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/12140467/pubmed\" id=\"12140467\" target=\"_blank\">",
"        12140467",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Oster-Schmidt C, Altmeyer P, and Stucker M, &ldquo;Successful Treatment of Basal Cell Carcinoma on the Face With Imiquimod 5% Cream,&rdquo;",
"      <i>",
"       Acta Derm Venereol",
"      </i>",
"      , 2002, 82(6):477.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/12575864/pubmed\" id=\"12575864\" target=\"_blank\">",
"        12575864",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shumack S, Robinson J, Kossard S, et al &ldquo;Efficacy of Topical 5% Imiquimod Cream for the Treatment of Nodular Basal Cell Carcinoma: Comparison of Dosing Regimens,&rdquo;",
"      <i>",
"       Arch Dermatol",
"      </i>",
"      , 2002, 138(9):1165-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/12224977/pubmed\" id=\"12224977\" target=\"_blank\">",
"        12224977",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Swanson N, Abramovits W, Berman B, et al, &ldquo;Imiquimod 2.5% and 3.75% for the   Treatment of Actinic Keratoses: Results of Two Placebo-Controlled Studies of Daily Application to the Face and Balding Scalp for Two 2-Week Cycles,&rdquo;",
"      <i>",
"       J Am Acad Dermatol",
"      </i>",
"      , 2010, 62(4):582-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/20133013/pubmed\" id=\"20133013\" target=\"_blank\">",
"        20133013",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tyring S, Conant M, Marini M, et al, &ldquo;Imiquimod; An International Update on Therapeutic Uses in Dermatology,&rdquo;",
"      <i>",
"       Int J Dermatol",
"      </i>",
"      , 2002, 41(11):810-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/59/20406/abstract-text/12453012/pubmed\" id=\"12453012\" target=\"_blank\">",
"        12453012",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8638 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-190.92.87.115-02329B04FB-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20406=[""].join("\n");
var outline_f19_59_20406=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182270\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182271\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182299\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182273\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182288\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182274\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182256\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182241\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182258\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182257\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182296\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182306\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182297\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10184536\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182245\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182294\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182250\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182252\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1630402\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182276\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182263\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182254\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182264\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182244\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182260\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8638\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8638|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?25/19/25908?source=related_link\">",
"      Imiquimod: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_59_20407="Epidemiology and control of echinococcosis";
var content_f19_59_20407=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology and control of echinococcosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20407/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20407/contributors\">",
"     Pedro L Moro, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20407/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20407/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20407/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20407/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/59/20407/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echinococcal disease is caused by infection with the tapeworm echinococcus. Four species of Echinococcus cause infection in humans. E. granulosus and E. multilocularis are the most common, causing cystic echinococcosis (CE) and alveolar echinococcosis (AE), respectively. The two other species, E. vogeli and E. oligarthrus, cause polycystic echinococcosis and are less frequently associated with human infection (",
"    <a class=\"graphic graphic_table graphicRef75863 \" href=\"UTD.htm?14/27/14781\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"     1",
"    </a>",
"    ]. Two relatively new species have been identified: Echinococcus shiquicus in small mammals from the Tibetan plateau and Echinococcus felidis in African lions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]; their transmission potential to humans is not known.",
"   </p>",
"   <p>",
"    The geographic distribution and animal host species vary by echinococcus species, and mixed infections involving more than one species have been reported. In addition, different strains within an echinococcus species may have variable morphology, genetic characteristics, infectivity to humans, and pathogenicity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology and control of the echinococcal species will be reviewed here. The clinical manifestations, diagnosis, and treatment of cystic and alveolar echinococcosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28025?source=see_link\">",
"     \"Clinical manifestations and diagnosis of echinococcosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/58/27561?source=see_link\">",
"     \"Treatment of echinococcosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5040041\">",
"    <span class=\"h1\">",
"     ECHINOCOCCUS SPECIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Echinococcus granulosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;E. granulosus causes cystic echinococcosis (CE).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24323976\">",
"    <span class=\"h3\">",
"     Life cycle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The life cycle of echinococcus includes a definitive host (usually dogs or related species) and an intermediate host (such as sheep, goats, camels, cervids, horses, cattle, and swine) (",
"    <a class=\"graphic graphic_figure graphicRef86230 \" href=\"UTD.htm?20/63/21496\">",
"     figure 1",
"    </a>",
"    ). Humans are incidental hosts; they do not play a role in the transmission cycle. E. granulosus adult tapeworms are usually found in dogs or other canids.",
"   </p>",
"   <p>",
"    The adult tapeworm inhabits the small intestine of the definitive host. The definitive host may be infected with thousands of worms. E. granulosus worms are usually 2 to 7 mm long and consist of a scolex with suckers and hooks, as well as at least three proglottid segments. E. multilocularis worms are up to 4 mm long with two to six proglottic segments.",
"   </p>",
"   <p>",
"    The tapeworm is composed of proglottid segments that have both male and female sexual organs and can produce parasite eggs 30 to 40 microm in size containing embryos (oncospheres). Each adult worm can produce thousands of eggs per day. The eggs are expelled in the stool of the definitive host and released to the environment, where they are infective to susceptible intermediate hosts and human incidental hosts. Eggs are highly resistant and can remain infective for a year in a moist environment at low temperature. For example, eggs of E. multilocularis can remain viable for 16 months in water at a temperature of 4&deg;C (39.2&deg;F) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/4\">",
"     4",
"    </a>",
"    ]. Eggs are sensitive to desiccation.",
"   </p>",
"   <p>",
"    Following egg ingestion by the intermediate or incidental host, the oncospheres hatch from the eggs, penetrate the intestinal mucosa, enter the blood",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lymphatic system, and migrate to the liver or other visceral organs. A few days later a fluid-filled cyst begins to develop, with subsequent development of multiple layers to become a metacestode (hydatid cyst). The nature of the cyst is variable depending on the echinococcal species (",
"    <a class=\"graphic graphic_table graphicRef81405 \" href=\"UTD.htm?29/2/29739\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Subsequently, protoscolices develop within the hydatid cyst. In definitive hosts that ingest intermediate host visceral organs containing hydatid cysts composed of protoscolices, the protoscolices evaginate, attach to the intestinal mucosa, and develop into adult worms. Such development occurs over a period of four to seven weeks, completing the life cycle.",
"   </p>",
"   <p>",
"    The highest rates of cystic echinococcal (CE) endemic disease tend to occur in areas where sheep are raised. Transmission frequently occurs in settings where dogs eat the viscera of slaughtered animals. The dogs then excrete infectious eggs in their stool, which are passed on to other animals or humans via fecal-oral transmission. This may occur via environmental contamination of water and cultivated vegetables, or contact between infected domestic dogs and humans (often in children).",
"   </p>",
"   <p>",
"    Human-to-human transmission of echinococcosis does not occur since two mammalian species are required for completion of the life cycle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystic hydatidosis is a significant public health problem in South America, the Middle East and Eastern Mediterranean, some sub-Saharan African countries, China, and the former Soviet Union [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The overall prevalence of echinococcal infection is underestimated in many series because systematic population surveys are not performed in all endemic areas. The number of recognized cases is increasing, however, which may be due in part to better diagnostic technology and surveillance programs.",
"   </p>",
"   <p>",
"    In endemic rural areas, prevalence rates of 2 to 6 percent or higher have been recorded [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/7\">",
"     7",
"    </a>",
"    ]. In the Peruvian Andes, observed prevalence rates in one study among humans, canines, and sheep were 9, 46, and 32 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In a Chinese region endemic for both E. granulosus and E. multilocularis, village prevalence rates for CE and alveolar echinococcus (AE) were 6.8 and 6.2 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/10\">",
"     10",
"    </a>",
"    ]. The prevalence of CE ranged from 0 to 12 percent; prevalence of AE prevalence ranged from 0 to 14 percent. These are among the highest rates recorded worldwide.",
"   </p>",
"   <p>",
"    New echinococcal infections continue to occur throughout life, and the prevalence of liver and pulmonary hydatid cysts increases with age. One study in Uruguay noted an overall prevalence of 5.6 percent; the prevalence increased from 1 percent among patients 4 to 6 years of age to &gt;11 percent among patients over 60 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the United States, most cases occur among immigrants from endemic countries. Local transmission has been observed in California, Arizona, New Mexico, Utah, and Alaska [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Molecular studies have identified several distinct strains of E. granulosus with different geographic and host affinities (",
"    <a class=\"graphic graphic_table graphicRef75863 \" href=\"UTD.htm?14/27/14781\">",
"     table 1",
"    </a>",
"    ). The presence of different strains of E. granulosus may have important implications for public health. For example, the shortened maturation time of the adult form of the parasite in the dog intestine (for E.granulosus strains G2, G5, and G6) suggests that the number of treatment doses per year may have to be increased in endemic areas for these strains [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hydatid cyst is usually filled with fluid (",
"    <a class=\"graphic graphic_table graphicRef81405 \" href=\"UTD.htm?29/2/29739\">",
"     table 2",
"    </a>",
"    ). The inner layer is the germinative layer that gives rise to the hydatid fluid and small secondary cysts (brood capsules), which bud internally from this layer. Fragmentation of the germinative layer and brood capsules gives rise to daughter cysts. These may develop within the original cyst or separately.",
"   </p>",
"   <p>",
"    After at least 10 to 12 months following infection, protoscolices are produced within the brood capsules. Cysts may contain liters of fluid and thousands of protoscolices. Cysts containing protoscolices are fertile and can produce daughter cysts, whereas cysts without protoscolices are sterile.",
"   </p>",
"   <p>",
"    External to the germinative layer is an acellular, laminated membrane of variable thickness. A host granulomatous reaction occurs around this membrane; the resulting parenchyma and fibrous tissue reaction is known as the pericyst.",
"   </p>",
"   <p>",
"    The pathology resulting from E. granulosus infection varies in different geographic regions and among different populations. Among patients in Turkana, Kenya, for example, many cysts are large, unilocular, and fertile [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/13\">",
"     13",
"    </a>",
"    ]. In contrast, cysts among individuals in the northern hemisphere tend to be calcified, small, and infertile [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"     1",
"    </a>",
"    ]. Such variations could depend upon a number of factors: the time between infection and diagnosis, intraspecies variation of the parasite, and host differences (immunologic, genetic,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nutritional) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermediate and incidental hosts mount both humoral and cellular immune responses to the organism. The initial immune response occurs against the oncospheres that penetrate the gastrointestinal mucosa. Subsequently, the host mounts an immune response against the metacestode (hydatid cyst). Metacestodes have developed highly effective mechanisms for evading host defenses. The membranes and host capsule surrounding the cyst protect the E. granulosus parasite from immune destruction [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other less well-defined mechanisms, including parasite-derived modulating substances such as an anticomplement factor, may also dampen the host immune response [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/14\">",
"     14",
"    </a>",
"    ]. Studies have suggested that Th1 cell activation is crucial for protective immunity, whereas Th2 cell activation is associated with susceptibility to progressive hydatid disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Echinococcus multilocularis",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95616227\">",
"    <span class=\"h3\">",
"     Life cycle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rodents serve as intermediate hosts for E. multilocularis; humans are incidental hosts who acquire infection by ingesting eggs shed in stool by the definitive host, typically foxes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"     1",
"    </a>",
"    ]. The embryos or oncospheres hatch from the egg in the small intestine and are transported to the liver where they form multilocular hydatid cysts. In humans, the larval mass resembles a malignancy in appearance and behavior, because it proliferates indefinitely by exogenous budding and invades the surrounding tissues. Unlike cystic echinococcosis (CE), protoscolices are rarely observed in human infection due to E. multilocularis. Fox and coyote populations have increasingly encroached upon suburban and urban areas of many regions, and as a result, domestic dogs or cats may become infected when they eat infected wild rodents [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alveolar echinococcosis (AE) due to E. multilocularis has been reported in parts of central Europe, much of Russia, the Central Asian republics, northeastern, northwestern, and western China, the northwestern portion of Canada, and western Alaska [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Foxes appear to play an important role in zoonotic transmission of E. multilocularis, as demonstrated by increases in the incidence of human AE in areas of Europe following an increase in the fox population, from a mean of 0.10 per 100,000 (during 1993 to 2000) to a mean of 0.26 per 100,000 (during 2001 to 2005) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The movement or relocation of foxes has also led to spread of the parasite from endemic to non-endemic areas in North America, as well as on the north island of Hokkaido, Japan. Hunters, trappers, and others who work with fox fur are often exposed to alveolar hydatid disease. Hyperendemic areas have been described in parts of China with prevalences as high as 15 percent in some villages.",
"   </p>",
"   <p>",
"    Human association with dogs that eat infected rodents can result in infection with the larval form of E. multilocularis. High prevalence rates have been reported in some Eskimo villages of the North American tundra, where local dogs feed on infected commensal rodents [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/18\">",
"     18",
"    </a>",
"    ]. In hyperendemic foci in villages of the North American tundra, dogs prey on wild rodents, which live as commensals in and around dwellings. In central Europe, infected foxes expel eggs, which are then eaten by rodents inhabiting cultivated fields and gardens; these in turn can become a source of infection for dogs. Individuals who own dogs that kill game or dogs that roam outdoors unattended are at increased risk for E. multilocularis AE infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/19\">",
"     19",
"    </a>",
"    ]. A higher risk of AE has also been observed among farmers. Foxes and rodents of the genera Microtus and Peromyscus are involved in the cycle in rural regions of central North America [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;E. multilocularis can cause severe infection in humans. The metacestode tissue behaves like a malignancy that invades and destroys tissue, extends beyond organ borders into adjacent structures, and can metastasize to distant sites [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1,14,21\">",
"     1,14,21",
"    </a>",
"    ]. In humans, disease spreads from primary infection in the liver to other organs, including the lungs and the brain, either by direct extension or hematogenous dissemination [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1,14\">",
"     1,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lesions are composed of numerous irregular cysts of various sizes, with no sharp demarcation from surrounding organ tissue. Mixed solid and cystic lesions are common. The lack of limiting membrane allows exogenous budding, proliferation, and infiltration into adjacent tissues, resulting in necrosis of surrounding host tissue. Central necrosis of the lesions is frequent, and irregular calcifications are seen in up to 70 percent of cases. Microscopically, the cysts are composed of a thin, laminated layer with minimal or no germinative layer. Brood capsules and protoscolices form in less than 10 percent of these cysts; instead, reproduction occurs by asexual lateral budding.",
"   </p>",
"   <p>",
"    Metacestodes can die spontaneously, followed by degeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients who become infected with E. multilocularis develop antibodies, although it is uncertain whether these antibodies play a role in controlling metacestode proliferation. T lymphocyte responses may be more important in controlling infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/23\">",
"     23",
"    </a>",
"    ]. In addition, animal models suggest that the parasite may actively impair host immune responses. In vitro, E. multilocularis infection reduces interleukin (IL)-2 receptor expression and IL-2 production, but increases IL-5 secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/23\">",
"     23",
"    </a>",
"    ]. Certain HLA antigens may also be involved in protection against or susceptibility to progressive infection. In patients with severe disease, for example, the frequency of HLA-DR 13 is increased five- to sixfold [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Echinococcus vogeli",
"    </span>",
"    &nbsp;&mdash;&nbsp;E. vogeli occurs in central and northern South America. Human infections have been reported in Panama, Ecuador, Colombia, Venezuela, Costa Rica, Argentina, Peru, and Brazil. The definitive hosts are dogs and other canids; the principal intermediate hosts are pacas and other rodents [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    E. vogeli causes polycystic hydatid disease. Large cysts with multiple vesicles separated by septae often form and may spread to contiguous sites. Brood capsules bud internally from the germinative epithelium that lines the septa. Externally, the cyst is surrounded by fibrous tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Polycystic echinococcosis (PE) is an emerging disease. In 1979, there were 12 cases in 4 countries, by 1997 there were 72 cases, and by 1998 there were 86 cases in 11 countries [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/25\">",
"     25",
"    </a>",
"    ]. As of 2007, 172 human cases of PE were recorded from Central and South America [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/25\">",
"     25",
"    </a>",
"    ]. Most cases of PE are due to E. vogeli. In one study including isolates from 72 human cases of PE in Central and South America in which species diagnosis was based on protoscolex hook morphology, 31 isolates were identified as E. vogeli and 3 were identified as E. oligarthus; species identification was not possible in the remaining 38 isolates [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, the clinical disease is more severe than cystic disease, but less severe than alveolar disease. The liver is involved in the majority of cases, and the lungs are involved in approximately 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/14,25\">",
"     14,25",
"    </a>",
"    ]. Progressive invasion of the liver and biliary tree may result in liver failure, portal hypertension, and biliary cirrhosis.",
"   </p>",
"   <p>",
"    The diagnosis is made by imaging or serology. Most available serologic tests are not able to differentiate E. vogeli from other echinococcal species, particularly E. multilocularis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/27\">",
"     27",
"    </a>",
"    ]. However, the species may be differentiated by microscopic evaluation of the larvae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Echinococcus oligarthrus",
"    </span>",
"    &nbsp;&mdash;&nbsp;E. oligarthrus occurs from northern Mexico to southern Argentina. Three human cases of E. oligarthrus infection have been reported in Venezuela and Brazil [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/26\">",
"     26",
"    </a>",
"    ]. The definitive hosts are wild felids such as the puma and the jaguar; the intermediate hosts include rodents and rabbits.",
"   </p>",
"   <p>",
"    E. oligarthrus causes polycystic hydatid disease. Metacestodes tend to be localized in muscles or other extrahepatic sites. The human cases have affected the eye (two cases) and the heart (one case).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24323576\">",
"    <span class=\"h1\">",
"     CONTROL OF ECHINOCOCCUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The likelihood of cystic echinococcosis infection can be reduced by avoiding close contact with dogs. Careful washing of fresh produce can also reduce the likelihood of infection. The life cycle of the parasite can be disrupted by preventing dogs from consuming infected sheep viscera, which generally occurs in settings where dogs reside in close proximity to areas where sheep are slaughtered. Elimination of stray dogs has helped reduce infection in some endemic areas [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/28\">",
"     28",
"    </a>",
"    ]. A traditional method for surveillance of E. granulosus among dogs consists of administering arecoline hydrobromide as a purging agent, with subsequent stool evaluation for worms or eggs. Stool antigen tests are a newer, safer, and effective surveillance technique [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/28\">",
"     28",
"    </a>",
"    ]. Administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"     praziquantel",
"    </a>",
"    treatment to infected dogs has been shown to reduce the number of human cases in some countries (eg, Iceland, Australia, and New Zealand) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/29\">",
"     29",
"    </a>",
"    ]. Control programs are underway in Argentina, Chile, Portugal, China, and many Mediterranean countries.",
"   </p>",
"   <p>",
"    Vaccination of sheep may also be useful for prevention of cystic echinococcosis; intermediate hosts are capable of developing protective immunity. A vaccine for E. granulosus, the EG95 vaccine, contains a purified recombinant protein of the parasite oncosphere as well as an adjuvant. Initially, two doses of the vaccine are administered one month apart, followed by a required annual booster [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/28,30-32\">",
"     28,30-32",
"    </a>",
"    ]. In field trials of EG95 in Australia and Argentina, 86 percent of vaccinated sheep were found to be completely free of viable hydatid cysts one year after immunization (compared to unvaccinated control sheep that were experimentally challenged with E. granulosus eggs); the vaccination reduced the number of viable cysts by 99 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/33\">",
"     33",
"    </a>",
"    ]. Another trial found that EG95 afforded 90 percent protection to cattle, and a third dose boosted protection to 99 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prevention of alveolar echinococcosis infection requires avoidance of contact with foxes and other potentially infected definitive hosts. There are rare reports of cats acting as definitive hosts, but these are of uncertain significance [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Reducing contact between pets and rodent prey is also important for control; intermittent prophylactic treatment of canids with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"     praziquantel",
"    </a>",
"    can also be effective. Monthly praziquantel given to dogs in a 10-year field trial in Alaska was effective in reducing egg contamination [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/37\">",
"     37",
"    </a>",
"    ]. No effective vaccine against E. multilocularis has been developed. Even if a vaccine became available, the primary cycle is almost always sylvatic, which makes a vaccination approach to control unlikely to be fully effective [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20407/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Delays in diagnosis of alveolar echinococcosis (AE) due to E. multilocularis can lead to progression of infection that cannot be managed with definitive surgery. Screening high risk populations for earlier detection of alveolar hydatid disease might improve prognosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/58/27561?source=see_link&amp;anchor=H27#H27\">",
"     \"Treatment of echinococcosis\", section on 'Alveolar echinococcosis (E. multilocularis)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Echinococcal disease is caused by infection due to the tapeworm echinococcus. Four species of echinococcus cause infection in humans. E. granulosus and E. multilocularis are the most common, causing cystic echinococcosis (CE) and alveolar echinococcosis (AE), respectively. The two other species, E. vogeli and E. oligarthrus, cause polycystic echinococcosis (PE) and are less frequently associated with human infection (",
"      <a class=\"graphic graphic_table graphicRef75863 \" href=\"UTD.htm?14/27/14781\">",
"       table 1",
"      </a>",
"      ). Two additional species have been identified (Echinococcus shiquicus in small mammals from the Tibetan plateau and Echinococcus felidis in African lions), but their transmission potential to humans is not known. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The life cycle of echinococcus includes a definitive host (usually dogs or related species) and an intermediate host (such as sheep, goats, or swine). Humans are incidental hosts; they do not play a role in the transmission cycle. (See",
"      <a class=\"local\" href=\"#H24323976\">",
"       'Life cycle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The adult tapeworm inhabits the small intestine of the definitive host, which may be infected with thousands of worms. The tapeworm is composed of proglottid segments, which can produce parasite eggs containing embryos (oncospheres). The eggs are expelled in the feces of the definitive host and released to the environment, where they are infective to susceptible intermediate hosts and human incidental hosts. (See",
"      <a class=\"local\" href=\"#H24323976\">",
"       'Life cycle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following egg ingestion by the intermediate or incidental host, the oncospheres hatch from the eggs, penetrate the intestinal mucosa, enter the blood",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      lymphatic system, and migrate to the liver or other visceral organs. A few days later, a fluid-filled cyst begins to develop, with subsequent development of multiple layers to become a metacestode (hydatid cyst). The nature of the cyst varies depending on the echinococcal species (",
"      <a class=\"graphic graphic_table graphicRef81405 \" href=\"UTD.htm?29/2/29739\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H24323976\">",
"       'Life cycle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Protoscolices develop within the hydatid cyst. In intermediate and incidental hosts, protoscolices become daughter cysts (secondary cysts). In definitive hosts that ingest intermediate host visceral organs containing hydatid cysts composed of protoscolices, the protoscolices evaginate, attach to the intestinal mucosa, and develop into adult worms. (See",
"      <a class=\"local\" href=\"#H24323976\">",
"       'Life cycle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CE due to E. granulosus is a significant public health problem in South and Central America, the Middle East and eastern Mediterranean, some sub-Saharan African countries, China, and the former Soviet Union. AE due to E. multilocularis occurs in the Northern Hemisphere, in parts of central Europe, Russia, western China, areas of North America, and northern Africa; it accounts for less than 5 percent of all cases of hydatid liver disease. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Echinococcus granulosus'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Echinococcus multilocularis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Control of echinococcosis infection requires avoidance of contact with dogs and other potentially infected definitive hosts. Careful washing of fresh produce can also reduce the likelihood of infection. Intermittent prophylactic treatment of canids with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"       praziquantel",
"      </a>",
"      can also be effective. Vaccination of sheep has been useful for prevention of cystic echinococcosis in some areas. (See",
"      <a class=\"local\" href=\"#H24323576\">",
"       'Control of echinococcus'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3174693\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate Inc. would like to acknowledge Dr. Karin Leder and Dr. Peter Weller, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/1\">",
"      Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/2\">",
"      Xiao N, Qiu J, Nakao M, et al. Echinococcus shiquicus, a new species from the Qinghai-Tibet plateau region of China: discovery and epidemiological implications. Parasitol Int 2006; 55 Suppl:S233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/3\">",
"      H&uuml;ttner M, Nakao M, Wassermann T, et al. Genetic characterization and phylogenetic position of Echinococcus felidis (Cestoda: Taeniidae) from the African lion. Int J Parasitol 2008; 38:861.",
"     </a>",
"    </li>",
"    <li>",
"     Eckert J, Gotstein B, Heath D, Liu FJ. Prevention of echinococcosis in humans and safety precautions. In: WHO/OIE Manual on Echinococcosis in Humans and Animals, Eckert J, Gemmell MA, Meslin FX, Pawlowski Z.  (Eds), Office International des E 'pizooties, Paris 2001. p.96.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/5\">",
"      Jenkins DJ, Romig T, Thompson RC. Emergence/re-emergence of Echinococcus spp.--a global update. Int J Parasitol 2005; 35:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/6\">",
"      Romig T, Dinkel A, Mackenstedt U. The present situation of echinococcosis in Europe. Parasitol Int 2006; 55 Suppl:S187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/7\">",
"      Moro P, Schantz PM. Cystic echinococcosis in the Americas. Parasitol Int 2006; 55 Suppl:S181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/8\">",
"      Moro PL, Bonifacio N, Gilman RH, et al. Field diagnosis of Echinococcus granulosus infection among intermediate and definitive hosts in an endemic focus of human cystic echinococcosis. Trans R Soc Trop Med Hyg 1999; 93:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/9\">",
"      Gavidia CM, Gonzalez AE, Zhang W, et al. Diagnosis of cystic echinococcosis, central Peruvian Highlands. Emerg Infect Dis 2008; 14:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/10\">",
"      Tiaoying L, Jiamin Q, Wen Y, et al. Echinococcosis in Tibetan populations, western Sichuan Province, China. Emerg Infect Dis 2005; 11:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/11\">",
"      Cohen H, Paolillo E, Bonifacino R, et al. Human cystic echinococcosis in a Uruguayan community: a sonographic, serologic, and epidemiologic study. Am J Trop Med Hyg 1998; 59:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/12\">",
"      Moro PL, Schantz PM. Echinococcosis: historical landmarks and progress in research and control. Ann Trop Med Parasitol 2006; 100:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/13\">",
"      MacPherson CN, Romig T, Zeyhle E, et al. Portable ultrasound scanner versus serology in screening for hydatid cysts in a nomadic population. Lancet 1987; 2:259.",
"     </a>",
"    </li>",
"    <li>",
"     Schantz P. Echinococcosis. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 1st ed, Guerrant R, Walker DH, Weller PF (Eds), WB Saunders, Philadelphia 1999. p.1005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/15\">",
"      Rigan&ograve; R, Profumo E, Ioppolo S, et al. Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin Exp Immunol 1995; 102:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/16\">",
"      Schweiger A, Ammann RW, Candinas D, et al. Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis 2007; 13:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/17\">",
"      Vuitton DA, Zhou H, Bresson-Hadni S, et al. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology 2003; 127 Suppl:S87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/18\">",
"      Wilson JF, Rausch RL. Alveolar hydatid disease. A review of clinical features of 33 indigenous cases of Echinococcus multilocularis infection in Alaskan Eskimos. Am J Trop Med Hyg 1980; 29:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/19\">",
"      Kern P, Ammon A, Kron M, et al. Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis 2004; 10:2088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/20\">",
"      Kapel CM, Torgerson PR, Thompson RC, Deplazes P. Reproductive potential of Echinococcus multilocularis in experimentally infected foxes, dogs, raccoon dogs and cats. Int J Parasitol 2006; 36:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/21\">",
"      Brunetti E, White AC Jr. Cestode infestations: hydatid disease and cysticercosis. Infect Dis Clin North Am 2012; 26:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/22\">",
"      Rausch RL, Wilson JF, Schantz PM, McMahon BJ. Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg 1987; 36:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/23\">",
"      Sturm D, Menzel J, Gottstein B, Kern P. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 1995; 63:1688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/24\">",
"      Gottstein B, Bettens F. Association between HLA-DR13 and susceptibility to alveolar echinococcosis. J Infect Dis 1994; 169:1416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/25\">",
"      Tappe D, Stich A, Frosch M. Emergence of polycystic neotropical echinococcosis. Emerg Infect Dis 2008; 14:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/26\">",
"      D'Alessandro A. Polycystic echinococcosis in tropical America: Echinococcus vogeli and E. oligarthrus. Acta Trop 1997; 67:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/27\">",
"      Gottstein B, D'Alessandro A, Rausch RL. Immunodiagnosis of polycystic hydatid disease/polycystic echinococcosis due to Echinococcus vogeli. Am J Trop Med Hyg 1995; 53:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/28\">",
"      Craig PS. Echinococcus granulosus: immunodiagnosis and vaccination, a perspective. Parassitologia 1997; 39:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/29\">",
"      Craig PS, Larrieu E. Control of cystic echinococcosis/hydatidosis: 1863-2002. Adv Parasitol 2006; 61:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/30\">",
"      Heath DD, Holcman B. Vaccination against echinococcus in perspective. Acta Trop 1997; 67:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/31\">",
"      Lightowlers MW, Lawrence SB, Gauci CG, et al. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol 1996; 18:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/32\">",
"      Heath DD, Jensen O, Lightowlers MW. Progress in control of hydatidosis using vaccination--a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. Acta Trop 2003; 85:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/33\">",
"      Lightowlers MW, Jensen O, Fernandez E, et al. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int J Parasitol 1999; 29:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/34\">",
"      Heath DD, Robinson C, Shakes T, et al. Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis). Vaccine 2012; 30:3076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/35\">",
"      Nonaka N, Hirokawa H, Inoue T, et al. The first instance of a cat excreting Echinococcus multilocularis eggs in Japan. Parasitol Int 2008; 57:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/36\">",
"      Dyachenko V, Pantchev N, Gawlowska S, et al. Echinococcus multilocularis infections in domestic dogs and cats from Germany and other European countries. Vet Parasitol 2008; 157:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/37\">",
"      Rausch RL, Wilson JF, Schantz PM. A programme to reduce the risk of infection by Echinococcus multilocularis: the use of praziquantel to control the cestode in a village in the hyperendemic region of Alaska. Ann Trop Med Parasitol 1990; 84:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20407/abstract/38\">",
"      McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet 2003; 362:1295.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5668 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.248.109.99-8AB70CBFC1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20407=[""].join("\n");
var outline_f19_59_20407=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5040041\">",
"      ECHINOCOCCUS SPECIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Echinococcus granulosus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24323976\">",
"      - Life cycle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Pathology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Echinococcus multilocularis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H95616227\">",
"      - Life cycle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Pathology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Echinococcus vogeli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Echinococcus oligarthrus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24323576\">",
"      CONTROL OF ECHINOCOCCUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3174693\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5668\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5668|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/63/21496\" title=\"figure 1\">",
"      Life cycle of echinococcosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5668|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/27/14781\" title=\"table 1\">",
"      Echinococcus species",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/2/29739\" title=\"table 2\">",
"      Echinococcal cyst features",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28025?source=related_link\">",
"      Clinical manifestations and diagnosis of echinococcosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/58/27561?source=related_link\">",
"      Treatment of echinococcosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_59_20408="Inguinal anatomy";
var content_f19_59_20408=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60403&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60403&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    Inguinal anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 474px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inguinal anatomy is illustrated in the panels above, progressing from anterior (A) to posterior (D) views. The inguinal canal is formed by the aponeurosis of the external oblique muscle anteriorly (A) and the transversalis fascia and the transversus abdominus muscle posteriorly (B,C). The external inguinal ring is formed by the external oblique muscle (A). The internal inguinal ring is located in the transversalis fascia and composed of the transversus abdominus and internal oblique muscles (B,C). The femoral vessels exit the abdomen posterior to the inguinal canal (D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from O'Rahilly. Abdominal walls. In: Basic Human Anatomy, W.B. Saunders Company, Philadelphia 1983. p.232.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20408=[""].join("\n");
var outline_f19_59_20408=null;
var title_f19_59_20409="Oral food challenges for diagnosis and management of food allergies";
var content_f19_59_20409=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Oral food challenges for diagnosis and management of food allergies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20409/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20409/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20409/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20409/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/59/20409/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/59/20409/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/59/20409/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of a food allergy requires consideration of the details of an individual's history, knowledge about the epidemiology of different food allergies, and specific test results. When these elements do not clearly confirm or refute an allergy, the clinician, typically an allergy specialist or sometimes a gastroenterologist, may perform a clinician-supervised oral food challenge (OFC) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. OFCs may also be used to determine if a food allergy has resolved. In addition, they can be undertaken to define other adverse reactions to foods, such as intolerance.",
"   </p>",
"   <p>",
"    OFCs generally consist of a gradual feeding of the test food under close observation. The test usually results in a definitive conclusion about whether the food was tolerated.",
"   </p>",
"   <p>",
"    An OFC is preceded by a period of dietary elimination, performed either therapeutically (because the food was already suspected or known to have caused a reaction) or for diagnostic reasons (to determine if elimination of the suspect food resulted in amelioration of symptoms).",
"   </p>",
"   <p>",
"    This topic review will present the role of diagnostic elimination diets, the selection of patients for OFCs, different types of OFCs, and a general approach to performing an OFC. Other related food allergy topics are covered separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=see_link\">",
"     \"Diagnostic evaluation of food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/17/26904?source=see_link\">",
"     \"History and physical examination in the patient with possible food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link\">",
"     \"The natural history of childhood food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ELIMINATION DIETS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elimination diets are performed prior to an oral food challenge. Elimination diets are used diagnostically to determine if symptoms, usually chronic in nature, resolve after the suspected food(s) is removed from the diet. Elimination diets are discussed in greater detail in another review, and avoidance of a food allergen once the allergy is diagnosed is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=see_link\">",
"     \"Diagnostic evaluation of food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are three types of elimination diets:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Elimination of one or several foods suspected to be causing symptoms",
"     </li>",
"     <li>",
"      Elimination of all but a defined group of \"allowed\" foods (oligoantigenic diet)",
"     </li>",
"     <li>",
"      An elemental diet consisting of a hydrolyzed formula or an amino acid-based formula",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The type of elimination diet chosen depends upon the clinical history and the results of specific IgE tests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Acute IgE-mediated reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient may be instructed to avoid several potential causal foods if a reaction suggesting an IgE-mediated disorder (eg, urticaria) occurred suddenly after a meal, but a single causal food allergen could not be identified by testing or history. It is improbable that more than one food in a given meal would cause a reaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Chronic illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elimination of multiple foods (eg, oligoantigenic or elemental diet) may be indicated for patients with certain chronic inflammatory diseases. For example, atopic dermatitis and eosinophilic gastrointestinal diseases are associated with food allergy that is usually non-IgE mediated or mixed IgE and non-IgE mediated [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. History, testing, and epidemiologic considerations may yield an extensive list of suspect foods. Thus, elimination of multiple foods is typically needed to determine if the disorder is food-responsive.",
"   </p>",
"   <p>",
"    Adherence to these diets is difficult, so exclusion of a modest number of high risk foods may be considered instead. A provisional diagnosis of food allergy is given if symptoms resolve, as documented by history, symptom diaries,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physical examination. However, OFCs are still needed to confirm the causal foods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR OFC",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oral food challenge serves two roles in managing food allergies: to confirm diagnosis of a specific food allergy, and to determine if an identified allergy persists or has resolved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Initial diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several settings in which clinician-supervised oral food challenges may be needed for diagnosis of food-allergic disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To allow expansion of the diet when several foods are under consideration as a cause of symptoms, based upon history, positive specific IgE tests, and resolution of symptoms after elimination of all the suspected foods.",
"     </li>",
"     <li>",
"      To evaluate foods that were removed from the diet or not introduced into the diet based primarily upon positive allergy tests [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      When a food is highly suspected to have caused a significant acute allergic reaction but specific IgE testing is negative.",
"     </li>",
"     <li>",
"      When a food is highly suspected as an allergen but elimination has not resulted in symptom resolution.",
"     </li>",
"     <li>",
"      If tests for specific IgE are not relevant (eg, enterocolitis syndrome) or only partly relevant (eg, atopic dermatitis or eosinophilic esophagitis) to the illness (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"       \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Assessing resolution",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children with known food allergies, OFCs are commonly performed to determine the safety of adding foods back into the diet when it is suspected that the allergy has resolved. Variables to consider when trying to determine if a food allergy has resolved include specific IgE tests, age of the individual, time since the last reaction, and the outcomes after recent accidental exposures, if any. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=see_link\">",
"     \"Diagnostic evaluation of food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link\">",
"     \"The natural history of childhood food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is generally no clinical reason to perform an OFC if there has been recent severe anaphylaxis to an isolated ingestion, with a positive test for specific IgE antibody to the causal food. In addition, an OFC may not be relevant when the food or food family being eliminated is not important to the allergic individual&rsquo;s diet and can be simply avoided (eg, a rarely ingested fruit).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DECIDING TO PROCEED TO AN OFC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical and patient factors must be considered when determining if it is appropriate to undertake an OFC (",
"    <a class=\"graphic graphic_table graphicRef55879 \" href=\"UTD.htm?5/26/5547\">",
"     table 1",
"    </a>",
"    ). Patient preferences and concerns are important to consider and should be discussed with the",
"    <span class=\"nowrap\">",
"     patient/family.",
"    </span>",
"   </p>",
"   <p>",
"    Factors",
"    to consider before proceeding with a food challenge include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Risk of reaction - The medical history, skin test results, and in vitro test results may be used to estimate the risk of current allergy. Data are conflicting as to whether increasing concentrations of food-specific antibodies and size of reactions on skin testing correlate with the severity of a reaction during a challenge, possibly because of additional factors affecting severity including dose ingested and comorbid conditions such as asthma [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/11-14\">",
"       11-14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=see_link\">",
"       \"Diagnostic evaluation of food allergy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"       \"Management of food allergy: Avoidance\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/17/26904?source=see_link\">",
"       \"History and physical examination in the patient with possible food allergy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link\">",
"       \"The natural history of childhood food allergy\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      As an example, a patient with an egg allergy had a reaction a few months ago after an accidental exposure. The in vitro test for food-specific IgE to egg is now negative. However, the prior probability that this patient is still allergic to egg is high, given the relatively recent reaction. A clinician may decide to proceed with the challenge if the skin test to egg is negative, as this indicates a lower likelihood of failing the challenge. Conversely, a challenge may be deferred if the patient has a large positive reaction on skin testing [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Patient/family",
"      </span>",
"      preference - Agreement upon the correct time to undertake a food challenge requires joint consideration by the clinician and the",
"      <span class=\"nowrap\">",
"       patient/family.",
"      </span>",
"      Some clinicians typically offer food challenges for young children when risks of having a reaction to the challenge are about 50 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/12,16\">",
"       12,16",
"      </a>",
"      ]. Others suggest challenges when the risk is higher, on the grounds that avoidance, especially of staple foods, is a significant burden [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/17\">",
"       17",
"      </a>",
"      ]. In contrast, some",
"      <span class=\"nowrap\">",
"       patients/families",
"      </span>",
"      may prefer to wait until there is a greater chance of passing the challenge.",
"      <br/>",
"      <br/>",
"      As an example, the family of a two-year-old child with a 90 percent risk of peanut allergy may not consider an oral food challenge worthwhile because the food is easily avoided and the chance of tolerating it may improve with time [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/18\">",
"       18",
"      </a>",
"      ]. Conversely, the same 10 percent prospect of tolerating peanut may be an adequate reason for a teenager to undergo a challenge to determine whether or not there is a reason to avoid the food in the coming years.",
"     </li>",
"     <li>",
"      Nutritional importance of the food - Food challenges may be indicated to allow expansion of the diet, despite poor odds of tolerance, in a child whose nutritional status is negatively impacted because of the avoidance of multiple foods [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Impact of a failed challenge - A child with fear of eating because of past severe reactions may warrant psychological treatment prior to OFC to reduce the risk that a failed OFC would increase food avoidance behaviors. Parental anxiety was lower after a DBPCFC, regardless of outcome, in one observational study [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other issues - OFCs should only be performed when the food is expected to become part of the diet. Infrequently, food allergy may recur after a negative challenge and has been associated with continued avoidance or infrequent ingestion of peanut [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/21,22\">",
"       21,22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    OFCs may not accurately reflect reactions outside of the challenge setting, because OFCs use a gradual administration of the tested food and the challenge is discontinued if symptoms occur [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/23\">",
"     23",
"    </a>",
"    ]. Thus, OFCs should not be undertaken solely to document severity.",
"   </p>",
"   <p>",
"    OFCs performed after a period of elimination have resulted in acute and severe reactions, even though the food was previously associated only with chronic symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/2,24,25\">",
"     2,24,25",
"    </a>",
"    ]. This occurs most commonly when there is a positive specific IgE test for the food. This risk must be considered prior to trial diagnostic elimination diets and during OFCs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TYPES OF FOOD CHALLENGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three general types of OFCs: open, single-blind, and double-blind challenges [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/1,26-28\">",
"     1,26-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Open OFC",
"    </span>",
"    &nbsp;&mdash;&nbsp;An open OFC involves gradually feeding the tested food in its natural state (eg, peanut butter) to patients who know that they are eating the food being tested. This method is potentially prone to patient and observer bias because of expectations of a reaction, but it is easy to perform since no special preparation is needed. There is little concern about bias if the patient tolerates the ingestion of the food. However, bias must be considered when symptoms develop, especially if they are subjective.",
"   </p>",
"   <p>",
"    Open challenges are a good option for screening when several foods are under consideration, or there is minimal concern about observer or patient bias. The test can be repeated with blinding and controls if there is a reaction to an open challenge and there is concern that the reaction may have been anxiety-related rather than physiologic. Open feeding is also used to follow a double-blind, placebo-controlled OFC to ensure a meal-sized portion of the food is tolerated in its natural state. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Single-blind OFC'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H12\">",
"     'Double-blind, placebo-controlled OFC'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Single-blind OFC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single-blind challenges require that the food be masked in taste by adding it to another food, or hidden in opaque capsules. This procedure helps to alleviate some patient bias. However, the single-blind OFC does not remove observer bias.",
"   </p>",
"   <p>",
"    The single-blind challenge may be performed with a placebo arm or the operator may decide to use initial placebo doses to observe for subjective symptoms prior to proceeding with the challenge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Double-blind, placebo-controlled OFC",
"    </span>",
"    &nbsp;&mdash;&nbsp;The double-blind, placebo-controlled, oral food challenge (DBPCFC) is considered the gold standard for diagnosing food allergy and is preferred for research purposes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/1,29\">",
"     1,29",
"    </a>",
"    ]. The tested food is hidden in another food or opaque capsules. Bias is reduced because there are at least two feedings and neither patient nor operator knows which challenges contain the food being tested.",
"   </p>",
"   <p>",
"    The procedure for DBPCFC is more labor intensive than the open or single-blind challenge, but it can still be carried out in an office setting if the required materials and personnel are available. The aid of a third party is needed to prepare the challenges. A coin flip can be used by the third party to randomize the order of administration. It is sometimes difficult to provide a meal-sized portion of a food in its natural state because the food is masked.",
"   </p>",
"   <p>",
"    The false positive and false negative rate for the DBPCFC, based primarily on studies in children with atopic dermatitis, is 0.7 percent and 3.2 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The placebo arm and active arm may be performed in a single day in patients with a history of IgE-mediated reactions. There should be several hours between challenges. The practice of interspersing placebo and active food proteins during a single challenge (ie, random ordering of sequential doses of placebo and suspected allergen) should be discouraged because it may be difficult to differentiate whether a reaction following a placebo dose was due to the placebo or other factor or was a delayed reaction to the suspected allergen.",
"   </p>",
"   <p>",
"    As noted above, an open feeding of a meal-size portion of the tested food prepared in its usual manner is often performed as a follow-up to any negative DBPCFC [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/31\">",
"     31",
"    </a>",
"    ]. A DBPCFC may need to be repeated using larger doses or different methods of food preparation if such an open feeding induces a reaction. Although DBPCFCs typically include only two separate challenges (a single placebo and only one active feeding component), increasing the number of challenges to both placebo and active allergen helps to diminish the possibility of a reaction due to chance rather than true allergy; however, this approach is very labor intensive [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PERFORMANCE OF AN OFC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consensus has not been reached on a uniform international protocol for performing oral food challenges [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/1,28,34\">",
"     1,28,34",
"    </a>",
"    ]. The protocol for oral food challenge (eg, dosing, frequency) may need to be varied to match clinical issues (eg, the history of the reaction pattern). In all challenges, the food is given in gradually increasing amounts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Patient preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Informed consent should be obtained from the patient or guardian, and documented prior to beginning the challenge.",
"   </p>",
"   <p>",
"    Patients should avoid the suspected food(s) for at least two weeks before the OFC for suspected IgE-mediated allergy and several weeks longer for non-IgE-mediated reactions. Patients should not eat or drink for at least two hours prior to challenge.",
"   </p>",
"   <p>",
"    Antihistamines, beta-agonists, beta-adrenergic blockers (including eye drops), and other medications that may either alter symptoms of a reaction or interfere with its treatment, should be discontinued for at least five half-lives (specific to each medication) prior to challenge. Patients should be instructed to bring their auto-injectable epinephrine to their appointment, so that it is available to them on the trip home after the test in the event of a delayed reaction.",
"   </p>",
"   <p>",
"    Patients are advised to cancel the OFC if they are experiencing acute allergic symptoms or are otherwise ill at the time of their appointment. Patients with asthma should be symptom-free and be stable on current therapy with no recent exacerbations. Spirometry may be performed to ensure a good baseline. Infrequently, hospitalization may be necessary to treat severe or acute allergic disease and establish a stable baseline prior to challenges.",
"   </p>",
"   <p>",
"    Children may be more cooperative if they are supplied with videos, games, and other distractions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Location",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral food challenges are almost always performed under direct medical supervision either in a clinic or hospital setting. Options for location include clinician offices, outpatient centers designed for procedures, inpatient hospital units, and monitored intensive care units. In unusual circumstances, foods may be gradually added back into the diet at home. This may be undertaken when specific IgE tests are negative, symptoms are mild or chronic, and there is little concern for potential anaphylaxis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link\">",
"     \"The natural history of childhood food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Selection of an appropriate setting requires clinician judgment about risks and availability of advanced treatment of anaphylaxis. Oral challenges can elicit severe anaphylactic reactions in any setting. The physician must have appropriate training and be prepared with emergency medications and equipment to promptly treat such a reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/2,35\">",
"     2,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is best to perform the challenge in a controlled setting (eg, hospital) if the patient is considered high risk (eg, positive test for IgE, previous anaphylactic reaction, history of asthma). It may also be prudent to have intravenous access prior to commencing challenges in patients with higher specific IgE levels [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/36\">",
"     36",
"    </a>",
"    ] or history of more severe reactions. Intravenous access should be strongly considered for all patients with food protein-induced enterocolitis syndrome (FPIES) undergoing a food challenge, since they are at risk for hypotension with reexposure to the food [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall level of risk associated with food challenges has been examined. A retrospective series reviewed 584 OFCs performed in children who were estimated to have a &le;50 percent risk of a reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/16\">",
"     16",
"    </a>",
"    ]. Forty-three percent of the challenges were positive. Thirty-nine percent of the reactions were mild, 33 percent moderate, and 28 percent severe. The type and incidence of the different reactions were cutaneous (78 percent), gastrointestinal (43 percent), oral (26 percent), lower respiratory (26 percent), and upper respiratory (25 percent). No patients had cardiovascular symptoms.",
"   </p>",
"   <p>",
"    In this series, there was no difference among foods in the severity of failed challenges or the type of treatment required to reverse symptoms, despite presumptions about certain foods causing more severe reactions than others (eg, peanut compared to egg or milk). All reactions were reversed with antihistamines without epinephrine, beta agonists,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    glucocorticoids. Patients were observed for a minimum of four hours after completion of the challenge, and none had a delayed reaction after discharge.",
"   </p>",
"   <p>",
"    Another series reviewed 150 food challenges performed in 109 patients aged 6 months to 18 years at a university-based pediatric allergy clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/38\">",
"     38",
"    </a>",
"    ]. Challenges were performed to either confirm an allergy or determine if an allergy had resolved. Patients with a history of severe cardiovascular symptoms were excluded from this series. The median IgE level at the time of the challenge was 1.22",
"    <span class=\"nowrap\">",
"     kUA/L",
"    </span>",
"    for milk, 0.96",
"    <span class=\"nowrap\">",
"     kUA/L",
"    </span>",
"    for peanut, and 0.65",
"    <span class=\"nowrap\">",
"     kUA/L",
"    </span>",
"    for egg. There were 40 (27 percent) positive challenges (milk,",
"    <span class=\"nowrap\">",
"     4/39;",
"    </span>",
"    peanut,",
"    <span class=\"nowrap\">",
"     12/37;",
"    </span>",
"    egg,",
"    <span class=\"nowrap\">",
"     13/29;",
"    </span>",
"    other,",
"    <span class=\"nowrap\">",
"     11/45).",
"    </span>",
"    Only three patients were graded as having severe reactions because they had wheezing. All other positive challenges were mild to moderate in severity and included skin, upper respiratory, and gastrointestinal manifestations. Reaction severity did not correlate with specific IgE level. Thirty-five percent of positive challenges were managed with observation only and 57 percent were treated with an antihistamine. No challenges induced cardiovascular symptoms or required treatment with epinephrine.",
"   </p>",
"   <p>",
"    Among 718 oral food challenges performed at our institution, most with a risk assessment of 50 percent or less, 36 percent were positive [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/39\">",
"     39",
"    </a>",
"    ]. Fifty-seven percent had isolated skin (n = 109) or gastrointestinal (n = 38) manifestations, and only 12 percent had respiratory symptoms. Antihistamines were administered for 93 percent of reactions, and 9 percent of positive challenges were treated with epinephrine. Thus, the clinician performing OFCs must be prepared to treat anaphylaxis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Food preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In blinded challenges, the allergenic food is hidden either in another food or in opaque capsules.",
"   </p>",
"   <p>",
"    Opaque capsules are easy to use, but pose several potential problems. Some patients, especially young children, are unable to ingest enough capsules or even swallow them at all. In addition, capsules can bypass oral contact, which would normally provide the earliest",
"    <span class=\"nowrap\">",
"     symptoms/clues",
"    </span>",
"    of a clinical response. Finally, slow degradation of capsules may result in overlapping doses (ie, administration of a subsequent dose before the previous dose was fully released). This can lead to unintended administration of a higher than needed dose to elicit symptoms and to more severe reactions.",
"   </p>",
"   <p>",
"    Alternatively, allergenic foods may be mixed into masking foods. Equipment used for food preparation includes paper plates, cups, disposable utensils, mixing bowls, scale,",
"    <span class=\"nowrap\">",
"     mortar/pestle,",
"    </span>",
"    blender, and a microwave. Suggestions for masking foods are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef64516 \" href=\"UTD.htm?19/18/19755\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. The following points should also be considered:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is often easier to mask liquid into liquid or to use powdered or dehydrated forms of foods that can be folded into solid vehicles.",
"     </li>",
"     <li>",
"      If a gritty allergen is being hidden in a vehicle, then a similarly gritty food should be added as placebo to the carrier vehicle. For example, for a challenge with ground oats hidden in apple sauce, corn meal may be mixed into apple sauce as a placebo.",
"     </li>",
"     <li>",
"      It is preferable not to use fatty foods as vehicles since they can delay gastric absorption [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Certain flavoring agents such as mint, tuna, or garlic can mask odors (such as the odor of peanut butter). However, it is important to select vehicles that are clearly tolerated by the patient.",
"     </li>",
"     <li>",
"      Measuring small amounts (eg, fractions of a mg) may be difficult and inaccurate; mixing and diluting the food in a carrier vehicle is often a more practical approach.",
"     </li>",
"     <li>",
"      Certain preparation methods (eg, canning, dehydration) may alter allergens [",
"      <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]. For this reason, a negative challenge should always be followed by an open feeding of the food, prepared in the way it is normally ingested. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Discontinuing a challenge'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Dosing and timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;No single approach to dosing and timing is universally established for food challenges. Dose amounts and timing between doses should be adjusted to match the patient's history (eg, if days of ingestion are needed to elicit symptoms) or concerns about heightened sensitivity (eg, starting with minimal doses spaced out over longer periods of observation).",
"   </p>",
"   <p>",
"    For example, a child with a history of atopic dermatitis flaring over days with milk ingestion, who carries positive IgE tests to milk and has been avoiding this protein for a year, may have an acute allergic reaction on the day of challenge or may experience a flare over days of ingestion. A graded oral food challenge under clinician supervision on the first day would evaluate the risk of an acute reaction, and, if tolerated, following the child's symptoms over the following days with milk added to the diet would evaluate for delayed responses.",
"   </p>",
"   <p>",
"    The general approach is to select a regimen that is unlikely to result in a severe acute reaction by cautiously and gradually increasing the amount ingested (with the target cumulative dose of a meal-sized portion), while also considering time constraints.",
"   </p>",
"   <p>",
"    For patients with past food reactions that occurred immediately after ingestion, doses are generally administered at 10 to 15 minute intervals over about 90 minutes, followed by a larger, meal-size portion of food a few hours later.",
"   </p>",
"   <p>",
"    Different dosing regimens are suggested when performing OFC for food protein induced enterocolitis syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Total dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;One approach used for DBPCFCs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/1,13,26\">",
"     1,13,26",
"    </a>",
"    ] is to administer a total of 8 to 10 grams of the dry food or 100 ml of",
"    <span class=\"nowrap\">",
"     wet/liquid",
"    </span>",
"    food (double amount for",
"    <span class=\"nowrap\">",
"     meat/fish,",
"    </span>",
"    eg, 20 grams). Dry forms of peanut (flour), milk, and egg are often used. The grams used may not match the protein content of ingested foods in their natural form. Powdered forms with a weight of 8 to 10 grams are approximately equivalent to 105 mL skim milk, 1.2 eggs, and 21 mL of peanut butter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Starting dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;The starting dose should be low enough that it does not trigger a reaction in most patients. In a small series of adult peanut allergic patients undergoing DBPCFCs, 50 mg of peanut was generally the lowest dose that elicited objective reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/45\">",
"     45",
"    </a>",
"    ]. However, one patient had a systemic reaction to a 5 mg dose. This patient and another experienced mild subjective symptoms at only 100 micrograms of peanut.",
"   </p>",
"   <p>",
"    Starting doses of 100 mg or less are recommended based upon results from a series of 513 positive challenges to six common allergenic foods in children with atopic dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/13\">",
"     13",
"    </a>",
"    ]. In this series, starting doses ranged from 100 to 500 mg. Neither prick skin test size or specific IgE antibody concentration was predictive of the dose required to trigger a reaction. Eleven percent of the reactions that occurred on first dose were severe. The following results were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 50 percent of children reacted at the first dose for egg and milk, 25 percent for soy, wheat, and peanut, and 15 percent for fish.",
"     </li>",
"     <li>",
"      Twenty-two percent of milk challenges and 8 percent of egg challenges were positive at a first dose of 250 mg.",
"     </li>",
"     <li>",
"      Three percent of milk and egg challenges were positive at a first dose of 100 mg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One could argue for starting doses that begin under the thresholds reported to induce reaction, especially in patients who have a history of reacting to trace amounts of a food [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/46\">",
"     46",
"    </a>",
"    ]. However, threshold data are not available for most foods and the thresholds that are published vary logarithmically. Reactions are usually not reported under 0.25 mg of protein for peanut (1 mg of peanut, an amount about the size of the head of a pin), 0.13 mg for egg (similar to the weight and volume of peanut butter), and 0.6 mg for milk (about 0.02 ml) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The European Academy of Allergology and Clinical Immunology proposed starting doses as follows (shown as protein weight or liquid volume): peanut 0.1 mg, milk 0.1 ml, egg 1 mg, cod 5 mg, wheat 100 mg, soy 1 mg, shrimp 5 mg, hazelnut 0.1 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Labial food challenge (placing the food on the lower lip for two minutes and observing for local or systemic reactions in the ensuing 30 minutes) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/49\">",
"     49",
"    </a>",
"    ], has been suggested by some as a starting point before an oral food challenge. However, this has not been extensively studied and we do not recommend this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Dose escalation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The total amount of food to be administered is given in escalating portions. As an example, for a milk challenge with the target dose of 100 mL (1 mL = 1 percent of the total dose), the doses could be: 1 percent, 4 percent, 10 percent, 20 percent, 20 percent, 20 percent, and 25 percent. However, a variety of other challenge regimens have been used, including lower starting doses, variations in the dosing increments, and different time intervals [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be examined carefully prior to an OFC to determine their baseline and to confirm that they do not have any current significant allergic",
"    <span class=\"nowrap\">",
"     signs/symptoms",
"    </span>",
"    or an illness that would interfere with assessment",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment of a reaction during the challenge. Vital signs are measured and signs and symptoms are recorded at baseline, prior to each dose, and at set intervals after the final dose. Assessments are made for symptoms affecting the skin, cardiovascular system, and gastrointestinal and respiratory tracts (",
"    <a class=\"graphic graphic_table graphicRef77080 \" href=\"UTD.htm?39/58/40876\">",
"     table 3",
"    </a>",
"    ). Scoring systems are useful in the research setting, but are not generally implemented in clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children may become suddenly quiet or assume a fetal position prior to exhibiting more objective symptoms. Early indications of a reaction can include subtle signs such as moving the tongue in the mouth to rub an itchy palate, or ear pulling as an indication of pruritus. Oropharyngeal pruritus or pain often precedes objective symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. Children with atopic dermatitis may display an eczematous flare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Discontinuing a challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;Challenges are terminated when a reaction becomes apparent (eg, new objective symptoms or an increase in objective symptoms over baseline). Expert judgment is needed about whether or not to discontinue a challenge if symptoms are not clear. Generally a challenge is discontinued if subjective symptoms are repetitive or prolonged.",
"   </p>",
"   <p>",
"    Following a negative oral food challenge in which the allergen was administered in a form not normally eaten (eg, peanut flour or powdered egg), it is essential to perform an open challenge with a meal-size portion of the food in the state in which it is normally ingested (eg, peanut butter or boiled egg). This is done to ensure that the processing of the allergenic food for challenge did not alter the allergen and to confirm the negative result.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Medical treatment for a reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications are given as needed to treat allergic or anaphylactic reactions. Generally, antihistamines are given at the earliest sign of a reaction. Epinephrine and other treatments are given if there is progression of symptoms or any potentially life-threatening symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severe allergic reactions are an uncommon outcome of oral food challenges in children when typical criteria are used in deciding to proceed with a challenge. In one series, anaphylactic reactions requiring treatment with epinephrine occurred in 4 percent of challenges (11 percent of positive challenges) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/52\">",
"     52",
"    </a>",
"    ]. These severe reactions more commonly occurred in older children and in children challenged to peanut or tree nuts. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Indications for OFC'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'Deciding to proceed to an OFC'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link&amp;anchor=H8#H8\">",
"     \"The natural history of childhood food allergy\", section on 'Monitoring the food-allergic child'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Full medical therapy (eg, epinephrine, antihistamines, intravenous fluids, oxygen, vasopressors, and H2-blockers), materials for resuscitation (ie, intubation), and personnel who can manage anaphylaxis should be immediately available. Doses for all rescue medications should be calculated in advance of challenges.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Observation following challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;After a negative oral food challenge, we typically observe a patient for one to two hours. It is possible to have later onset symptoms, and we extend this period if the history suggests delayed reactions or if prior reactions were severe. We inform the patient not to eat more of the test food that day and to report and treat any symptoms. The food is added to the diet the next day if no delayed symptoms are reported.",
"   </p>",
"   <p>",
"    Following a positive challenge, we observe patients for a minimum of two hours past resolution of mild symptoms that required minimal treatment and at least four hours for more significant reactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Post-challenge counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who tolerate a challenge require counseling about how to introduce or reintroduce the food. Typically, the food is started in the diet in normal portions the day after the challenge. Some patients and parents may continue to be fearful about eating the food, despite a negative challenge [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/53\">",
"     53",
"    </a>",
"    ], and this can result in continued avoidance [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/54\">",
"     54",
"    </a>",
"    ]. Patients and parents should be counseled that delayed reactions or reactions to a normal serving size of the food eaten all at once can occur, usually within a few days of the challenge, but they should also be reassured that these reactions are rare. As noted above regarding peanut, avoidance or infrequent exposure may result in resensitization to the allergen. It is therefore important to encourage normal incorporation of the food into the diet. Patients should be asked at subsequent visits about regular ingestion of the former allergen. A repeat challenge may be required in patients who have continued to avoid the food.",
"   </p>",
"   <p>",
"    Patients who have had a negative OFC to one allergen may have remaining food allergies. These patients must be cautioned specifically about cross contamination by foods that are commonly associated with the food that they are now able to ingest.",
"   </p>",
"   <p>",
"    Some patients may wish to continue carrying epinephrine even when there are no remaining food allergies. Patients may be advised to continue to have epinephrine available until it is clear that the food is tolerated as a routine part of the diet [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who have failed the OFC can be partly consoled to know that their hard work at avoidance was necessary. Though reactions may vary and strict avoidance is typically advised, knowledge about the dose causing symptoms may provide helpful information to patients and families [",
"    <a class=\"abstract\" href=\"UTD.htm?19/59/20409/abstract/55\">",
"     55",
"    </a>",
"    ]. Review of food avoidance measures is also helpful. The nutritional impact of food avoidance should be reevaluated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/27/35250?source=see_link\">",
"       \"Patient information: Food allergy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/47/29429?source=see_link\">",
"       \"Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral food challenges (OFCs) are a means to determine definitively if an allergy or other adverse reaction is related to a food, and to determine if an identified food allergy has resolved. These challenges are typically undertaken by allergy specialists, and occasionally by gastroenterologists. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Indications for OFC'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Elimination diets are undertaken prior to introducing a food during an OFC. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Elimination diets'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      OFCs may be performed as open feedings, single-blind, or double-blind placebo-controlled studies. The potential for bias will determine the type of OFC to be performed. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Types of food challenges'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      OFCs are generally performed by gradually feeding the test food, under supervision, with personnel and emergency treatments available in the event of anaphylaxis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Performance of an OFC'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dosing amount and regimen, location of challenge (eg, in a clinic, hospital, or monitored unit), and preparation of the patient with intravenous access is determined by assessment of various risk factors. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Performance of an OFC'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A successful oral food challenge requires ingestion of a meal-sized portion of the tested food prepared in its usual state. It is uncommon for subsequent reactions to occur if the feeding was tolerated. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Performance of an OFC'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/1\">",
"      Bock SA, Sampson HA, Atkins FM, et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol 1988; 82:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/2\">",
"      American College of Allergy, Asthma, &amp; Immunology. Food allergy: a practice parameter. Ann Allergy Asthma Immunol 2006; 96:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/3\">",
"      Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, et al. Work Group report: oral food challenge testing. J Allergy Clin Immunol 2009; 123:S365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/4\">",
"      NIAID-Sponsored Expert Panel, Boyce JA, Assa'ad A, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010; 126:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/5\">",
"      Fiocchi A, Sch&uuml;nemann HJ, Brozek J, et al. Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report. J Allergy Clin Immunol 2010; 126:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/6\">",
"      Ranc&eacute; F, Deschildre A, Villard-Truc F, et al. Oral food challenge in children: an expert review. Eur Ann Allergy Clin Immunol 2009; 41:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/7\">",
"      Eigenmann PA, Sicherer SH, Borkowski TA, et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101:E8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/8\">",
"      Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol 1999; 104:S114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/9\">",
"      Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/10\">",
"      Fleischer DM, Bock SA, Spears GC, et al. Oral food challenges in children with a diagnosis of food allergy. J Pediatr 2011; 158:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/11\">",
"      Wainstein BK, Studdert J, Ziegler M, Ziegler JB. Prediction of anaphylaxis during peanut food challenge: usefulness of the peanut skin prick test (SPT) and specific IgE level. Pediatr Allergy Immunol 2010; 21:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/12\">",
"      Perry TT, Matsui EC, Kay Conover-Walker M, Wood RA. The relationship of allergen-specific IgE levels and oral food challenge outcome. J Allergy Clin Immunol 2004; 114:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/13\">",
"      Sicherer SH, Morrow EH, Sampson HA. Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol 2000; 105:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/14\">",
"      Shreffler WG, Beyer K, Chu TH, et al. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 2004; 113:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/15\">",
"      Knight AK, Shreffler WG, Sampson HA, et al. Skin prick test to egg white provides additional diagnostic utility to serum egg white-specific IgE antibody concentration in children. J Allergy Clin Immunol 2006; 117:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/16\">",
"      Perry TT, Matsui EC, Conover-Walker MK, Wood RA. Risk of oral food challenges. J Allergy Clin Immunol 2004; 114:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/17\">",
"      Celik-Bilgili S, Mehl A, Verstege A, et al. The predictive value of specific immunoglobulin E levels in serum for the outcome of oral food challenges. Clin Exp Allergy 2005; 35:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/18\">",
"      Skolnick HS, Conover-Walker MK, Koerner CB, et al. The natural history of peanut allergy. J Allergy Clin Immunol 2001; 107:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/19\">",
"      Ald&aacute;miz-Echevarr&iacute;a L, Bilbao A, Andrade F, et al. Fatty acid deficiency profile in children with food allergy managed with elimination diets. Acta Paediatr 2008; 97:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/20\">",
"      Zijlstra WT, Flinterman AE, Soeters L, et al. Parental anxiety before and after food challenges in children with suspected peanut and hazelnut allergy. Pediatr Allergy Immunol 2010; 21:e439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/21\">",
"      Busse PJ, Nowak-Wegrzyn AH, Noone SA, et al. Recurrent peanut allergy. N Engl J Med 2002; 347:1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/22\">",
"      Fleischer DM, Conover-Walker MK, Christie L, et al. Peanut allergy: recurrence and its management. J Allergy Clin Immunol 2004; 114:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/23\">",
"      Hourihane JO, Grimshaw KE, Lewis SA, et al. Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community? Clin Exp Allergy 2005; 35:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/24\">",
"      David TJ. Anaphylactic shock during elimination diets for severe atopic eczema. Arch Dis Child 1984; 59:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/25\">",
"      Flinterman AE, Knulst AC, Meijer Y, et al. Acute allergic reactions in children with AEDS after prolonged cow's milk elimination diets. Allergy 2006; 61:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/26\">",
"      Sicherer SH. Food allergy: when and how to perform oral food challenges. Pediatr Allergy Immunol 1999; 10:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/27\">",
"      Niggemann B, Rolinck-Werninghaus C, Mehl A, et al. Controlled oral food challenges in children--when indicated, when superfluous? Allergy 2005; 60:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/28\">",
"      Bindslev-Jensen C. Standardization of double-blind, placebo-controlled food challenges. Allergy 2001; 56 Suppl 67:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/29\">",
"      Sampson HA, Gerth van Wijk R, Bindslev-Jensen C, et al. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma &amp; Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol 2012; 130:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/30\">",
"      Caffarelli C, Petroccione T. False-negative food challenges in children with suspected food allergy. Lancet 2001; 358:1871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/31\">",
"      Sampson HA. Use of food-challenge tests in children. Lancet 2001; 358:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/32\">",
"      Briggs D, Aspinall L, Dickens A, Bindslev-Jensen C. Statistical model for assessing the proportion of subjects with subjective sensitisations in adverse reactions to foods. Allergy 2001; 56 Suppl 67:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/33\">",
"      Chinchilli VM, Fisher L, Craig TJ. Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge. J Allergy Clin Immunol 2005; 115:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/34\">",
"      Niggemann B, Wahn U, Sampson HA. Proposals for standardization of oral food challenge tests in infants and children. Pediatr Allergy Immunol 1994; 5:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/35\">",
"      Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. American Academy of Allergy and Immunology. J Allergy Clin Immunol 1986; 77:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/36\">",
"      Reibel S, R&ouml;hr C, Ziegert M, et al. What safety measures need to be taken in oral food challenges in children? Allergy 2000; 55:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/37\">",
"      Sicherer SH. Food protein-induced enterocolitis syndrome: case presentations and management lessons. J Allergy Clin Immunol 2005; 115:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/38\">",
"      Mankad VS, Williams LW, Lee LA, et al. Safety of open food challenges in the office setting. Ann Allergy Asthma Immunol 2008; 100:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/39\">",
"      Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 2005; 115:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/40\">",
"      Vlieg-Boerstra BJ, Bijleveld CM, van der Heide S, et al. Development and validation of challenge materials for double-blind, placebo-controlled food challenges in children. J Allergy Clin Immunol 2004; 113:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/41\">",
"      van Odijk J, Ahlstedt S, Bengtsson U, et al. Double-blind placebo-controlled challenges for peanut allergy the efficiency of blinding procedures and the allergenic activity of peanut availability in the recipes. Allergy 2005; 60:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/42\">",
"      Grimshaw KE, King RM, Nordlee JA, et al. Presentation of allergen in different food preparations affects the nature of the allergic reaction--a case series. Clin Exp Allergy 2003; 33:1581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/43\">",
"      Chatterjee U, Mondal G, Chakraborti P, et al. Changes in the allergenicity during different preparations of Pomfret, Hilsa, Bhetki and mackerel fish as illustrated by enzyme-linked immunosorbent assay and immunoblotting. Int Arch Allergy Immunol 2006; 141:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/44\">",
"      Bernhisel-Broadbent J, Strause D, Sampson HA. Fish hypersensitivity. II: Clinical relevance of altered fish allergenicity caused by various preparation methods. J Allergy Clin Immunol 1992; 90:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/45\">",
"      Kilburn SA, Nordlee JA, Hefle SL, et al. An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol 1997; 100:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/46\">",
"      Taylor SL, Hefle SL, Bindslev-Jensen C, et al. A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much? Clin Exp Allergy 2004; 34:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/47\">",
"      Taylor SL, Hefle SL, Bindslev-Jensen C, et al. Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol 2002; 109:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/48\">",
"      Bindslev-Jensen C, Ballmer-Weber BK, Bengtsson U, et al. Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy 2004; 59:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/49\">",
"      Rance F, Dutau G. Labial food challenge in children with food allergy. Pediatr Allergy Immunol 1997; 8:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/50\">",
"      Kok EE, Meijer Y, Kentie PA, et al. Oropharyngeal symptoms predict objective symptoms in double-blind, placebo-controlled food challenges to cow's milk. Allergy 2009; 64:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/51\">",
"      Flinterman AE, Hoekstra MO, Meijer Y, et al. Clinical reactivity to hazelnut in children: association with sensitization to birch pollen or nuts? J Allergy Clin Immunol 2006; 118:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/52\">",
"      J&auml;rvinen KM, Amalanayagam S, Shreffler WG, et al. Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children. J Allergy Clin Immunol 2009; 124:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/53\">",
"      Flammarion S, Santos C, Romero D, et al. Changes in diet and life of children with food allergies after a negative food challenge. Allergy 2010; 65:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/54\">",
"      Eigenmann PA, Caubet JC, Zamora SA. Continuing food-avoidance diets after negative food challenges. Pediatr Allergy Immunol 2006; 17:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/59/20409/abstract/55\">",
"      Flinterman AE, Pasmans SG, Hoekstra MO, et al. Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children. J Allergy Clin Immunol 2006; 117:448.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2399 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-22FFA76FCA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20409=[""].join("\n");
var outline_f19_59_20409=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ELIMINATION DIETS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Acute IgE-mediated reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Chronic illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      INDICATIONS FOR OFC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Initial diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Assessing resolution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DECIDING TO PROCEED TO AN OFC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TYPES OF FOOD CHALLENGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Open OFC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Single-blind OFC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Double-blind, placebo-controlled OFC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PERFORMANCE OF AN OFC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Patient preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Location",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Safety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Food preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Dosing and timing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Total dose",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Starting dose",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Dose escalation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Discontinuing a challenge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Medical treatment for a reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Observation following challenge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Post-challenge counseling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2399\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2399|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/26/5547\" title=\"table 1\">",
"      Factors to consider pre OFC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/18/19755\" title=\"table 2\">",
"      Materials for OFCs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/58/40876\" title=\"table 3\">",
"      Signs symptoms allergic reaction during OFC",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=related_link\">",
"      Diagnostic evaluation of food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/17/26904?source=related_link\">",
"      History and physical examination in the patient with possible food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=related_link\">",
"      Management of food allergy: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/27/35250?source=related_link\">",
"      Patient information: Food allergy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/47/29429?source=related_link\">",
"      Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=related_link\">",
"      The natural history of childhood food allergy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_59_20410="Balloon valvuloplasty in pulmonic stenosis";
var content_f19_59_20410=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F88377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F88377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 512px\">",
"   <div class=\"ttl\">",
"    Balloon valvuloplasty in pulmonic stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 492px; height: 590px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Percutaneous balloon valvuloplasty for typical pulmonic valvular stenosis is an effective and safe procedure for those with moderate to severe stenosis. A balloon cathether is shown positioned across the stenotic pulmonic valve. The balloon is inflated to dilate the pulmonic valve opening. The cross-sectional image on the left shows obstruction of the pulmonic valve orifice prior to the valvuloplasty.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: LifeART. Copyright &copy; 2013 Lippincott Williams &amp; Wilkins. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20410=[""].join("\n");
var outline_f19_59_20410=null;
var title_f19_59_20411="Lead chelating agents A";
var content_f19_59_20411=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F59995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F59995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chelating agents used in the treatment of childhood lead poisoning",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Product name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Generic name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Chemical name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Abbreviation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium disodium versenate",
"       </td>",
"       <td>",
"        Edetate disodium calcium",
"       </td>",
"       <td>",
"        Calcium disodium ethylenediamine-tetracetate",
"       </td>",
"       <td>",
"        CaNa",
"        <sub>",
"         2",
"        </sub>",
"        EDTA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        BAL* in oil",
"       </td>",
"       <td>",
"        Dimercaprol",
"       </td>",
"       <td>",
"        2,3-dimercapto-propanol",
"       </td>",
"       <td>",
"        BAL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cuprimine",
"       </td>",
"       <td>",
"        D-penicillamine",
"       </td>",
"       <td>",
"        3-merecapto-d-valine",
"       </td>",
"       <td>",
"        D-penicillamine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chemet",
"       </td>",
"       <td>",
"        Succimer",
"       </td>",
"       <td>",
"        Meso -2,3-dimercapto- succinic acid",
"       </td>",
"       <td>",
"        DMSA",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * British anti-Lewisite.",
"    </div>",
"    <div class=\"reference\">",
"     www.atsdr.cdc.gov/csem/lead/pbmanage_therapy2.html",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20411=[""].join("\n");
var outline_f19_59_20411=null;
var title_f19_59_20412="Tests for chronic meningitis";
var content_f19_59_20412=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potentially useful diagnostic tests in patients with unexplained chronic meningitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Examination of cerebrospinal fluid (CSF)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cell count with differential",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Special stains (for specific pathogens, eosinophils)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cryptococcal antigen testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cultures (CSF, blood, other fluids where relevant)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aerobic and anaerobic bacterial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycobacterial (including acid fast stains)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fungal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Serology (blood and/or CSF)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fungal serologic tests for Histoplasma, Coccidioides, Sporothrix, Cryptococcus (CF or immunodiffusion)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toxoplasma serologies (IFA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antibody tests for HIV-1, HTLV I/II (ELISA, Western blot)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cysticercosis serology (ELISA, immunoblot)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lyme serologies (ELISA, Western blot)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VDRL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brucella serology (standard tube agglutination, CF, ELISA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tularemia serology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Imaging studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Computed tomography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Magnetic resonance imaging",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tuberculin skin tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meningeal or cortical biopsy (histopathology and culture)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow aspiration and biopsy (with cultures)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extractable nuclear antigens",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythrocyte sedimentation rate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20412=[""].join("\n");
var outline_f19_59_20412=null;
var title_f19_59_20413="Causes of pneumatosis";
var content_f19_59_20413=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diseases associated with pneumatosis intestinalis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Intraabdominal catastrophe:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intestinal ischemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intestinal infarction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intestinal perforation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intestinal obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Necrotizing enterocolitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Typhlitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_left\">",
"            Mucosal disruption:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Peptic ulcer disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Crohn's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ulcerative colitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Feeding jejunostomy tube",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Caustic ingestions",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ruptured diverticulum",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_left\">",
"            Infections:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Clostridium difficile",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberculosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Whipples disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            AIDS entrocolitides",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cryptosporidium",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Mycobacterium avium",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Intracellulare",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cytomegalovirus (CMV)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Pulmonary disorders:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic obstructive pulmonary disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Asthma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cystic fibrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mechanical ventilation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_left\">",
"            Endoscopic procedures:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Esophagogastroduodenoscopy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Colonoscopy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sclerotherapy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Endoscopic retrograde cholangiopancreatography (ERCP)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_left\">",
"            Diseases affecting gastrointestinal motility:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Diabetes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Scleroderma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hirschprung's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intestinal pseudoobstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Jejunoileal bypass",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pyloric stenosis/obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_left\">",
"            Immunological disturbances:",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            AIDS",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Steroids",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chemotherapy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphoproliferative disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bone marrow transplantation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Solid organ transplantation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Graft versus host disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amyloidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Collagen vascular disease",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20413=[""].join("\n");
var outline_f19_59_20413=null;
var title_f19_59_20414="Prevention and treatment of neonatal RDS";
var content_f19_59_20414=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73111&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73111&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prevention and treatment of neonatal respiratory distress syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 355px; height: 505px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Algorithm for management of neonatal respiratory distress syndrome based on gestational age. Note that criteria for initial surfactant therapy, subsequent doses of surfactant, and need for intubation and ventilatory support vary between institutions.",
"    <div class=\"footnotes\">",
"     CPAP: continuous positive airway pressure; IPPV: intermittent positive pressure ventilation; FiO",
"     <sub>",
"      2",
"     </sub>",
"     : fraction of inspired oxygen; ABG: arterial blood gas.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20414=[""].join("\n");
var outline_f19_59_20414=null;
var title_f19_59_20415="TEE transverse view of aortic rupture";
var content_f19_59_20415=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transesophageal echocardiography transverse view of aortic rupture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transesophageal echocardiography transverse view&nbsp;of traumatic subadventitial rupture of the aortic isthmus. There is a thick and highly mobile medial flap associated with a localized deformity of the anterolateral aortic wall due to the acute formation of a pseudoaneurysm (small arrow). The flap is thicker than the intimal flap seen with aortic dissection, since the entire depth of the intima and media are involved with aortic rupture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of P Vignon, MD and RM Lang, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_59_20415=[""].join("\n");
var outline_f19_59_20415=null;
